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THESIS ABSTRACT  
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    OVERVIEW 
This thesis presents several innovative techniques to rapidly evaluate particle stability in suspension based pressurized metered dose inhalers.  
Chapter 1 provides a review of the current techniques. Chapters 2, 3, and 4 discuss the improvement and application of liquid colloidal probe microscopy to evaluate the nano-scale interactions between particles of various porosities in a model propellant. It was found that particle porosity and morphology can have a significant effect on these interactions, yet direct measurement of the particle internal architecture can be challenging. Thus in chapter 5, a novel technique using nano X-Ray computer tomography was developed to visualize and quantify the internal porosity of such inhalable sized particles. To control particle porosity, various manufacturing processes such as freeze and spray drying are required. These processes can largely affect particle physical stability when formulated in propellant; therefore, in chapter 6 an innovative technique using isothermal microcalorimetry was developed to directly evaluate particle stability in pMDI formulations. Chapter 7 further conveys the versatility of pressurized isothermal microcalorimetry to evaluate various other pMDI particle parameters such as amorphicity, excipient compatibility, and moisture ingress. Detailed abstracts of each chapter are presented below.  
11 
     CHAPTER 1  
Several improvements in particle engineering techniques, including but not limited to spray drying, freeze drying, and supercritical fluid precipitation have greatly enhanced the ability to control the structure, morphology, and solid state phase of inhalable sized particles. However, to optimize particles for suspension based pMDI formulations a number of particle properties should be measured. This chapter features a literature review examining current and recently developed techniques for evaluating bulk and individual particle properties in air, model propellant, and hydrofluoroalkane propellants. 
This chapter has been published in Current Pharmaceutical Design, 2015; with the title ‘A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.’ Authors: D’Sa D, Chan HK.  
     CHAPTER 2 
Colloidal probe microscopy is an enticing technique that can measure inter-particle and particle-container attractive and adhesive forces expected to exist when particles are suspended in formulation. To conduct CPM measurements, a colloidal probe must first be prepared with a particle of interest. This task is of exceptional difficulty, with the current techniques available, especially when preparing probes with inhalable sized particles (1 - 5 µm) or smaller. In this published chapter, an improved method is presented for accurately preparing micron and nano functional colloidal probes to evaluate particle interactions existent in drug suspensions. The method improves upon the limitations of those 
12 
previously published, by using custom designed cantilever and particle slide holders and a room temperature workable epoxy with a specific viscosity of 14,000 cP at 25°C. These material improvements in addition to specific technique improvements allow for rapid and reproducible production of colloidal probes. Prepared probes were functional even during liquid force measurements in a model propellant medium (HPFP). A video depiction of the technique is available in the electronically published version of the article online.  
This chapter has been published in Journal of Colloid and Interface Science, 2014; 426:190-198, with the title ‘Attachment of Micro- and Nano-Particles on Tipless Cantilevers for Colloidal Probe Microscopy.’ Authors: D’Sa D, Chan HK, Chrzanowski W. 
     CHAPTER 3 
In addition to properly preparing colloidal probes, several other parameters, if not properly controlled, can produce erroneous results during liquid based CPM. This protocol centered chapter outlines key steps required to set up software parameters, calibrate probe spring constants and sensitivities, and obtain accurate force measurements in liquid CPM. Additionally, this chapter discusses preventive techniques to mitigate several instabilities associated with liquid measurements such as background noise, evaporation, and unstable approach/retract rates. Following this protocol, colloidal probes can be used in a liquid propellant medium to obtain rough particle topographies and measure inter-particle forces that develop either instantaneously or over an extended contact time 
13 
(dwell). A methodological video is available in the electronically published version of the article online. 
This chapter has been published in Journal of Visualized Experiments, 2014; 89: e51874-e51874, with the title ‘Quantitative and Qualitative Examination of Particle-Particle Interactions using Colloidal Probe Nanoscopy.’ Authors: D’Sa D, Chan HK, Kim HW, Chrzanowski W. 
     CHAPTER 4 
A subsequent publication, presented in this chapter, explores the interactions between inhalable particles of various porosities in a model propellant (HPFP), using probes prepared as detailed in chapter 2 and measurement techniques detailed in chapter 3. Previously, such interactions were evaluated using CPM instantaneous forces; however, such measurements fail to appropriately emulate all interactions present in a pMDI. Inter-particle adhesive forces in a pMDI normally develop over extended periods of contact rather than instantaneously. Therefore, lengthier dwell measurements such as indentation and deflection were employed to predict true adhesive particle interactions. Dwell measurements were conducted at various contact times up to 180 seconds. Deflection dwell mimicked interactions of a suspension that flocculated but did not partition, while indentation dwell mimicked interactions of a suspension formulation in which the two phases (propellant and particles) fully separated resulting in a particle cream or sediment layer. Adhesive forces measured with indentation dwell were foretelling of particle 
14 
agglomerate re-dispersability after prolonged storage. Increasing particle porosity reduced inter-particle attractive and adhesive forces and further resulted in a reduction in adhesive forces as a function of time for indentation dwell measurements. Additionally, CPM force values were predictive of phase separation rates measured by laser diffraction techniques (TurbiscanTM) and may also be predictive of dose uniformity. 
This chapter has been published in European Journal of Pharmaceutics and Biopharmaceutics, 2014; 88.1: 129-135, with the title ‘Predicting Physical Stability in Pressurized Metered Dose Inhalers via Dwell and Instantaneous Force Colloidal Probe Microscopy.’ Authors: D’Sa D, Chan HK, Chrzanowski W. 
     CHAPTER 5 
In the previous chapter, internal particle morphology was shown to have a significant effect on interactions that dictate particle partitioning in suspension based pMDIs; however, limited techniques are available to evaluate the internal morphology of inhalable sized particles. Chapter 5 presents a novel non-destructive technique for visualizing and quantifying the internal structure of these particles using nano X-ray computer tomography (NanoXCT). Various spray drying techniques were used to produce different inhalable sized particles for NanoXCT analysis. BSA particles were spray dried from solution, nanomatrix BSA particles from a suspension, lipid-based carriers from an emulsion, and PLGA particles from a double emulsion. Commercially available mannitol and HβCD were also evaluated for comparison. NanoXCT produced cross-sectional and 3-
15 
dimensional images of the particles allowing clear visualization of the internal and overall particle structure. Furthermore, the use of 3D rendering analysis software, such as Avizo Fire, allowed quantification of the size, shape, and distribution of all internal voids and structures. 3D rendered depictions of the particles are available in the electronically published version of the article online. 
This chapter has been published in Pharmaceutical Research, 2014; 1-10, with the title ‘NanoXCT: A Novel Technique to Probe the Internal Architecture of Pharmaceutical Particles.’ Authors: D’Sa D, Wong J, Foley M, Chan JGY, Chan HK.  
     CHAPTER 6 
The manufacturing techniques used to control particle morphology, not only affect inter-particle interactions as shown in chapter 3, but also affect the physical stability of the individual particles in propellant. For example, the fast solvent removal steps associated with spray drying can produce partially or fully amorphous particles, which may be highly unstable when formulated with propellants (HFA 134a/227).  Due to the low boiling temperature of the hydrofluoroalkane propellants used in pMDIs, there are limited techniques currently available to directly study them. In this chapter, a novel technique was developed to directly evaluate pMDI formulations using isothermal microcalorimetry. 4 mL pressure ampoules (rated to 10 bars) were fitted with specific nitrile O-rings and coated with soft paraffin to safely contain HFA134a-based formulations. Properly applying paraffin onto the ampoule cap, pre-conditioning the O-ring, and filling the ampoules near 
16 
capacity allowed reproducible stable measurement baselines using a Thermal Activity Monitor III (TAM III). Using this method the stability of spray dried amorphous beclomethasone dipropionate and formoterol fumarate dihydrate pMDI formulations were evaluated. Amorphous beclomethasone dipropionate particles crystallized rapidly into a clathrate form when exposed to HFA 134a, while amorphous formoterol fumarate dihydrate particles remained physically stable for the entirety of the measurement.  
This chapter has been published in Pharmaceutical Research, 2014; 31 (10): 2716-2723, with the title ‘Isothermal Microcalorimetry of Pressurized Systems I: A Rapid Method to Evaluate Pressurized Metered Dose Inhaler Formulations.’ Authors: D’Sa D, Lechuga-Ballesteros D, Chan HK.  
     CHAPTER 7 
A subsequent publication, presented in this chapter, expands on the use of pressurized isothermal microcalorimetry by evaluating the effect of excipients and water content on the stability of amorphous glycopyrrolate (GP) based pMDIs. Spray dried amorphous glycopyrrolate particles rapidly crystallized into elongated crystals when exposed to propellant, and co-spray drying with distearoyl-sn-glycero-3-phosphatidylcholine and calcium chloride dihydrate failed to stabilize the particles in propellant. However, co-spray 
drying with β-cyclodextrin (βCD) protected the amorphous glycopyrrolate from crystallization at water contents below 100 ppm. At water levels above 100ppm the protective nature of the co-spray dried βCD-GP particle was lost and the formulation 
17 
became unstable. Using isothermal microcalorimetry it was possible to rapidly evaluate several excipients and the effect of various water contents, effectively mimicking moisture ingress expected over an extended storage time.  
This chapter has been published in Pharmaceutical Research, 2014; 1-9, with the title ‘Isothermal Microcalorimetry of Pressurized Systems II: Effect of Excipient and Water Ingress on Formulation Stability of Amorphous Glycopyrrolate.’ Authors: D’Sa D, Lechuga-Ballesteros D, Chan HK.  
     CHAPTER 8 
The collective major findings of the previous chapters are reiterated within this chapter. Three techniques were developed to evaluate particle stability in suspension-based pressurized metered dose inhalers.  
• Colloidal Probe Microscopy improvements provide adhesion values that are more representative of particle suspensions during normal pMDI use.   
• Nano X-Ray Computer Tomography was successfully used to visualize and quantify the internal pore/void structure of inhalable particles. 
• Isothermal Microcalorimetry using pressurized ampoules and carefully controlled experimental parameters allowed for thermal analysis of engineered particles directly in propellant.  
Future projects as well as challenges that can affect further development of the above-mentioned methods are also discussed.  
18 
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INTRODUCTION 
  
20 
    RESEARCH PROBLEM 
Pressurized metered dose inhalers (pMDIs) are a popular form of drug administration via the pulmonary route. The pulmonary route is a more efficient delivery pathway for not only pulmonary diseases but several other diseases as well. However, as with most formulations, the process to develop a marketable, stable, robust, and efficacious product is extremely lengthy and costly. Additionally, because pMDIs contain low boiling temperature propellants, which exert exceptional pressures within the inhaler device at room temperature, there are a limited amount of analytical techniques that can be used to rapidly evaluate and test these formulations.  
    OBJECTIVES AND AIMS 
The overall objective of the work described in this thesis was to investigate various novel techniques to evaluate particle stability in suspension-based pressurized metered dose inhaler formulations. The experimental approach focused on three techniques, Colloidal Probe Atomic Force Microscopy, Nano X-Ray Computer Tomography, and Pressurized Isothermal Microcalorimetry, to evaluate different stability aspects of engineered particles. Methods developed for these techniques may allow for more rapid development and evaluation of pressurized metered dose inhaler formulations.  
  
21 
In order to achieve this goal, a series of specific objectives were developed: 
1. Perform a literature review of the current techniques and methods used to evaluate physical stability of suspension based pMDIs, assessing their strengths and limitations.  2. Develop a method and the appropriate techniques to produce micro and nano functional colloidal probes that can be used in CPM to evaluate particle interactions in a model propellant.  3. Examine the key methodological steps required to conduct accurate and reproducible CPM measurements in a model propellant or liquid medium.  4. Evaluate the effect of particle porosity on expected long-term particle interactions present within a pMDI and how they affect bulk suspension properties such as particle partitioning and re-dispersability using CPM.  5. Investigate the use of NanoXCT to visualize and quantify the internal porosity of inhalable sized particles produced via spray drying.  6. Develop an isothermal microcalorimetric method to directly evaluate the stability of spray dried inhalable particles in propellant. 7. Apply isothermal microcalorimetry to evaluate various formulation parameters such as excipient compatibility and water ingress.  
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    RESEARCH PROGRESS 
The work performed to achieve each objective is individually presented as Chapters 1 through 7 in this thesis. Chapters 2, 3, 4, 5, 6 and 7 have been published as research papers and are presented without edits to the text, figures or tables, but have been reformatted to provide continuity with the rest of the thesis. Chapter 1 has been submitted for publication and has been formatted in a similar manner for the thesis. Concluding remarks and future research directions are given in Chapter 8. 
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CHAPTER 1 
 
 
A REVIEW OF METHODS FOR EVALUATING PARTICLE STABILITY IN SUSPENSION BASED PRESSURIZED METERED DOSE INHALERS 
 
 
 
This chapter has been published in Current Pharmaceutical Design, 2015; with the title ‘A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers.’ Authors: D’Sa D, Chan HK. 
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1.  ABSTRACT 
Advances in particle engineering techniques, such as spray drying, freeze drying, and supercritical fluid precipitation have greatly enhanced the ability to control the structure, morphology, and solid state phase of inhalable sized particles (1 - 5 µm) for formulation in pressurized metered dose inhalers (pMDI). To optimize the properties of these engineered particles for formulation in hydrofluoroalkane propellants (HFA 134a / 227) it is necessary to measure both bulk and individual particle properties before, after, and during formulation. This review examines established and recently developed methods for evaluating a variety of particle properties including but not limited to size, surface and internal morphology, chemical composition, and solid state phase. Novel methods for evaluating particle stability directly in propellant or environments similar are also discussed. 
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2. INTRODUCTION 
Pressurized metered dose inhalers (pMDIs), since their development in 1956 (1), have become an important drug delivery method via the pulmonary route to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Today, pMDIs are employed not only to deliver drugs, but are also under consideration for the aerosol delivery of proteins, vaccines, and gene therapeutic agents to treat a variety of diseases (2, 3). The main function of pMDIs is to aerosolize a solution or suspension formulation to produce/release respirable-sized particles. To achieve proper aerosolization, formulations must contain a propellant that can maintain a consistent vapor pressure throughout the life of the product. Chlorofluorocarbons (CFCs) were used until 1995 when they were determined detrimental to the ozone layer (4). Swift actions were taken to replace CFCs with a more environmentally acceptable propellant, and hydrofluoroalkanes (HFA) such as HFA 134a and HFA 227 emerged as suitable replacement candidates. 
The switch to hydrofluoroalkanes, although resolving most environmental concerns, resulted in new formulation challenges. Changes to propellant density, wetting properties, and drug and excipient solubility (5, 6) prevented the direct transfer of formulation strategies that worked for CFCs to HFAs. For suspension-based pMDIs these challenges were perpetuated in: particle partitioning (creaming/sedimenting), particle aggregation and growth due to crystallization, and particle-container adhesion. In the original CFC formulations, dissolved surfactants such as oleic acid, sorbitan triethanoleate, and soya derived lecithin were included to improve suspension stability; however, several of these 
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surfactants were not soluble in HFAs and thus ineffective in HFA-based suspensions (7, 8). Efforts to improve drug particle stability in the new propellants have led to a significant growth in the field of particle engineering. Particle engineering is the art of using tools such as spray drying, spray freeze drying, crystallization, and precipitation to control and manipulate particle morphological and compositional properties (9-11). These properties can then be optimized for stability in HFA.  
However, to optimize particle properties for physical, chemical, and suspension stability, there is a need for analytical techniques that can accurately measure stability in the expected formulation/device combination. Analytical methods to evaluate various properties of suspension-based pMDIs (i.e. particle size, morphology, physical/chemical stability, and suspension quality) have not progressed or improved as rapidly as formulation design methods largely due to the constraints of working with propellants that possess low boiling temperatures. HFA 227 and HFA 134a, the most commonly used HFAs, exert a vapour pressure of 3.90 and 5.72 bars at 20°C and at 40°C increase to 7.03 and 10.16 bars, respectively (12). Thus, analysis of these systems requires appropriate safety controls and the ability to conduct measurements within a pressurized environment. In addition to the pressure difficulties, analytical techniques must be capable of measuring suspended particles of 1 - 5 µm in size, required for efficient pulmonary delivery, and even < 1 µm with the developments in nano-particle engineering (13). Therefore, there is a need for the development of analytical techniques to aid in the evaluation of suspension based pMDIs, preferably in the native HFA environment. In this article the authors review several techniques that are currently available to evaluate particle stability in pressurized metered 
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dose inhalers. Techniques reviewed include those to evaluate bulk particle suspension and individual particle stability in propellant.  
3. METHODS TO EVALUATE SUSPENSION STABILITY 
Particle partitioning, such as the creaming or sedimenting of suspended particles, is a major concern during development of suspension-based pMDIs. Partitioning is primarily driven by particle flocculation, since the formation of floccules results in an increase in effective particle radius (r) and thus by Stokes sedimentation equation (Equation 1) will have an exponential increase in particle partitioning velocities (ν).   
ν =  2g(ρP −  ρf)r2
9η
 E Q U A T I O N  1   where g is the gravitational constant, ρP and ρf the densities of the particle and liquid medium, respectively, and η the viscosity of the liquid medium. In addition to particle size, flocculation and particle partitioning are affected by particle solubility, morphology, crystallinity, density, surface energy and physical interactions. Control of the partitioning rate is particularly important to maintain uniform dosing throughout the life of the pMDI (i.e. last dose same as the first). Formulations with inherent rapid sedimentation or creaming, even after vigorous agitation, will result in high or low initial doses, respectively. Some techniques available to measure flocculation, particle partitioning, and the particle properties in propellant that affect these phenomena are presented below.  
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3.1  Visual Observation 
The simplest and most accessible technique normally used to evaluate suspension stability is bulk visual observation. Formulations are filled into borosilicate glass vials (which may or may not contain a protective polymer coating) by direct suspension filling using an automated or manual filler (i.e. Pamasol) or through transfer from a pre-filled pMDI using continuous valves. For analysis, vials are shaken for a set amount of time and visually observed on the bench top for flocculation and particle partitioning (Figure 1). This process is ideal for evaluating significant bulk differences between formulations; however, smaller changes in formulation or particle properties, as expected during optimization, may not allow for visual differentiation. Use of a height metric can reduce some operator subjectivity, but the technique is mostly dependent on operator judgment.  
 F I G U R E  1  
Visual observation of creaming/sedimenting tendencies of suspension-based pMDIs 
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3.2  Optical Light Scattering Techniques 
Light scattering techniques offer a more quantitative approach to determining partitioning and flocculation rates, by measuring the transmission and backscatter signal of a laser beam directed at the sample. Two systems using this technique that are discussed in literature include the Optical Suspension Characterization (OSCAR) and TurbiscanTM (14, 15). Both instruments utilize light scattering principles and may be used to scan the entire height of the sample (TurbiscanTM) or a fixed location(s) in the sample (OSCAR & TurbiscanTM) (16). Care must be taken when conducting full length scans, since samples that change significantly in the time required to complete a single scan (~30 seconds) will provide impractical results, due to the inability to obtain an appropriate baseline of the initial dispersed system. Full length scans are ideal for formulations that remain stable for periods much greater than the scan time and can clearly differentiate between and provide flocculation and particle partitioning rates (17). In a full length scan, flocculation is easily measured as an overall decrease in backscattering along the entire length of the sample, while partitioning is identified by location specific changes in the backscattering signal at the top and bottom of the sample. However, as is the case for most pMDIs, flocculation and partitioning occur more rapidly (typically within 60 seconds) and full length scans are not feasible. For such systems, TurbiscanTM and OSCAR can operate in fixed point measurement modes, where a fixed height for measurement is chosen (18). The height chosen for measurement should be dependent on the parameter being measured. A set point chosen within a fully creamed/sedimented layer (Figure 2B;β) will provide minimal information on the rate of flocculation since all particles measured at this point will likely already be 
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flocculated. Relevant to pMDIs, analysis at the height of the refill port on the metered valve (Figure 2A;α) would provide results on the suspension flocculation/partitioning rates past this key component feature.  
 F I G U R E  2  
Depiction of fixed height that may be used during TurbiscanTM or OSCAR analysis; (A) 
the location indicated by ‘α’ is where the valve refill port is located at a height of ‘h’ 
from the filled can. This height is important because creaming past this location will 
affect the amount of drug delivered in the next dosage (B) The location indicated by ‘β’ 
is situated within the creamed particle layer and will not likely provide valuable data, 
while the location indicated by ‘γ’ is located just below the creamed particle layer and 
would provide a measurement of completed particle partitioning  
Additionally, evaluating a fixed point just below or above the creamed or sedimented particle layer (Figure 2B;γ) can provide information on the length of time required for complete partitioning of the formulation. A key limitation of fixed point mode is the difficulty to separate the effects of partitioning and flocculation, since both events affect the 
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measurement signal. One way to differentiate the two phenomena could entail modifying the systems to allow fixed-point analysis at several heights that span the entire length of the sample simultaneously, thus allowing for a full snapshot of the sample instantaneously. Another concern in TurbiscanTM analysis is the delay between sample agitation and measurement, which exists due to the time required to place the sample in the instrument, seal the door, and position the laser at the set height before measurement can begin. In normal patient use, pMDIs are actuated within a few seconds of agitation and the metered chamber in the valve is refilled shortly after. Thus, the need for a built in agitation mechanism to the instrumentation would be beneficial. None-the-less, TurbiscanTM and OSCAR provide a more quantitative and objective technique than visual observation for measuring bulk particle flocculation and partitioning rates in a pressurized propellant environment.  
3.3  Aerosol Testing: Delivered Dose Uniformity 
Measuring delivered dose uniformity (DDU) is another technique that can indirectly measure particle suspension stability in pMDIs. DDU is useful for determining the amount of drug or excipient delivered per actuation throughout the life of a pMDI. A set number of actuations are collected at the beginning, middle, and end of the canister life using a dosing unit sampling apparatus (DUSA). DUSAs are washed using an appropriate solvent and the collected sample analyzed via HPLC. To facilitate quicker sample acquisition, automated instruments are utilized to waste doses between tested actuations. Instrument settings can be chosen to mimic patient shaking and actuating practices. Changes in delivered dose throughout the life of the pMDI are suggestive of particle partitioning rates (18). An 
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increase in delivered dose is indicative of a creaming formulation, while a decrease in delivered dose, a sedimenting formulation. Furthermore, the magnitude of the change would be an indication of the partitioning rates, with a larger change conveying a faster partitioning rate. Caveats to using this method to strictly analyze particle suspension stability are the confounding effects of the container closure components, parameters used to collect actuations, and the need to fully actuate the formulation to completion. Propellant vapor pressure changes due to emptying of the canister, drug interactions with container closure components, and valve design are just a few of the many factors that can affect DDU results. Therefore, decreases in delivered doses may also be indicative of increased particle deposition on container components (can walls, valve) and increases in delivered doses may be a result of increasing suspension concentration due to increased vaporization of propellant within the canister. Thus, DDU testing is not an ideal method to directly evaluate particle suspension stability.   
3.4  Colloidal Probe Microscopy 
The techniques reviewed so far, are beneficial to measure the effect of large changes in bulk particle properties on suspension quality; however they are unable to measure the particle interactions that govern flocculation and partitioning. Colloidal probe microscopy (CPM), a technique based on the same principle as atomic force microscopy (AFM), uses a colloidal particle as the probing feature instead of a sharpened conical or pyramidal tip. Colloidal probes can be prepared with virtually any single micron or nano-sized spherical particle (19), which allows direct measurement of particle interactions pertinent to the formulation (20). This method has been employed to study inter-particle and particle-canister 
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interactions of common inhalable drugs for treatment of COPD in a model liquid propellant (2H, 3H Perfluoropentane) comparable to HFA 227 and HFA 134a (21-23). Additionally, CPM has been used to evaluate the effect of particle surface energies and polymeric stabilizing excipients on inter-particle interactions using instantaneous force measurements in a model propellant (24). Instantaneous force measurements provide valuable information on the particle attractive forces that govern floccule formation. However, the adhesive forces measured using instantaneous force are less meaningful. During CPM instantaneous force mode, colloidal probes are brought into contact with the sample and once contact is achieved, immediately retracted. In a pMDI formulation, suspended particles are expected to remain in contact for extended periods of time once floccules are formed. The expected particle contact time is affected by the length of storage between patient uses.  
Therefore, to measure the adhesive forces that must be overcome to properly redisperse a formulation after storage, it is necessary to extend particle contact time during CPM measurement. This can be achieved through the use of deflection and indentation dwell modes in CPM. Deflection dwell mode involves keeping a colloidal probe and sample in contact (as expected for a formed floccule) for a set amount of time before retracting the probe (Figure 3A). However, as discussed earlier, the formation of floccules normally results in rapid particle partitioning, and thus the inter-particle forces during pMDI storage are expected to be more significantly affected by the compressive forces of the several particle layers attempting to reach the most stable partitioned state. Therefore, indentation dwell mode, which involves compressing the colloidal probe at a constant force (as 
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expected to occur in a fully partitioned particle layer) (Figure 3B), may provide a more applicable measurement of inter-particle adhesive forces (25). The contact time of dwell measurements can be set from a few seconds to several minutes, which allows analysis as a function of contact time. Furthermore, dwell measurements can also be used to evaluate interactions expected to occur between the particles and container closure components. 
 F I G U R E  3  
Depiction of the two different dwell types and their applicability to particle 
interactions expected within a suspension-based pMDI (A) dwell deflection (B) dwell 
indentation (Reprinted from European Journal of Pharmaceutics and Biopharmaceutics, 88.1, D’Sa D, Chan 
H-K, Chrzanowski W, Predicting Physical Stability in Pressurized Metered Dose Inhalers via Dwell and 
Instantaneous Force Colloidal Probe Microscopy, 129-135, 2014, with permission from Elsevier.) 
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The quantitative abilities of CPM can be useful in differentiating between smaller changes in particle properties than those measurable with bulk methods. However, it is important to note that variability in CPM measurements can be greatly affected by particle surface morphology (26, 27) and thermal instabilities that may arise from the use of a model propellant that is volatile. Thus, conducting all liquid based measurements in an enclosed liquid cell within a thermally controlled environment and limiting large morphological surface differences between particles if possible will greatly reduce experimental variability. Additionally, the production of colloidal probes, containing a single particle of 1 - 5 µm diameter attached to the apex of a cantilever and prominent of any glue used for the attachment, is a difficult task that can be dependent on the ability of the operator, since precise manipulation is required (19).  
An assumption of this technique is that single particle-particle forces measured are representative of all the forces present in formulation. Particle interactions of large agglomerates may be different than individual particle interactions. Therefore, it may be prudent to conduct colloidal probe measurements with particle agglomerates as well, although consistency of morphological contact areas will be greatly affected. Additionally, the interactions measured in the model propellant are not always directly transferable to formulations containing HFA 134a, HFA 227, or any combination thereof, due to differences in propellant properties and differing particle surface energies in the propellants; thus, the ability to directly obtain CPM measurements in a propellant or propellant mixture that is used in formulation would be beneficial. Such measurements have been previously limited by the commercial unavailability of AFMs that can 
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accommodate liquid cells that can withstand the necessary 4 - 6 atm of pressure required to contain and ensure propellants remain liquid during measurement. However, recent advances in modifying commercial AFMs may allow such measurements (28). Lea et al recently modified the setup of an AFM to withstand pressures up to 100 atm at temperatures of 350K to enable in situ atomic scale topographical measurements of solid surfaces in contact with supercritical CO2. The same set-up could be a very promising means to directly evaluate particle forces in HFA propellants. 
4.  METHODS TO EVALUATE BULK PARTICLE PROPERTIES  
 As mentioned earlier, particle properties such as size, morphology, density, and surface chemistry have a significant impact on pMDI suspension stability. Thus, analysis of such properties is required during formulation development and particle engineering optimization. A variety of techniques available to measure particle properties are listed in Table 1. Several of these techniques are well established within the pharmaceutical and inhalation industry and are not within the scope of this paper to discuss in detail. However, from those techniques listed, NanoXCT is a recently developed technique that will be discussed briefly.   
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 T A B L E  1  
Techniques to Measure Various Particle Properties 
Property Method Measures References 
Size  Light Diffraction Particle Sizing  Optical Size (29-31)  Cascade Impactors Aerodynamic Size (32-34)  Time of Flight & Laser-Doppler Velocimetry Aerodynamic Size (35-37)     
Surface Morphology  Surface Fractal Dimension Surface Roughness & Area (38, 39) 
 Scanning Electron Microscopy (SEM) Surface Visualization (40, 41) 
 Atomic Force Microscopy (AFM) Surface Roughness & Morphology (42-44)  Braunauer-Emmett-Teller Surface Area (BET) Surface Area / Porosity (45)     
Internal Morphology  Confocal Microscopy Internal Morphology (46, 47) 
 Freeze-fracture and Transmission Electron Microscopy (TEM) Internal Morphology (48-51)  Focused-Ion Beam Scanning Electron Microscopy (FIB-SEM) Internal Morphology (52, 53)  Nano X-Ray Computer Tomography Internal Morphology (54)     
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Property Method Measures References 
Chemistry & Composition 
 Inverse Gas Chromatography (IGC) Charge & Surface Polarity (55) 
 Thermo-Gravimetric Analysis (TGA) Solvent Content, Decomposition, & Solid State Phase  (56, 57) 
 Dynamic Vapour Sorption (DVS) Hygroscopicity, Hydration/Solvation & Amorphicity   (58-60) 
 X-Ray Powder Diffraction (XRPD) Crystallinity & Solid State phase/structure (61) 
 Differential Scanning Microcalorimetry (DSC) Thermal Properties, Phase Changes & API interactions (62) 
 Fourier Transform Infrared Spectroscopy (FTIR) Chemical Interactions & Compositions (63) 
 Raman Spectroscopy  Chemical Interactions, Compositions, Amorphous Content & Identification (64-66) 
 Nuclear Magnetic Resonance Spectroscopy (NMR) Chemical Interactions, Compositions, Amorphous Content & Identification (67) 
 High Performance Liquid Chromatography (HPLC) & Ultraviolet Spectroscopy  Quantify Concentration & Identify Composition  
 Isothermal Microcalorimetry Hydration/Solvation, Amorphicity,  Decomposition, & Component Interactions  (60, 68-71) 
 Karl Fischer Titration Moisture Content (72) 
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4.1  Nano X-Ray Computer Tomography 
Nano X-Ray Computer Tomography (NanoXCT) is a non-destructible imaging technique recently applied to visualize and quantify the internal morphology of inhalable sized particles. NanoXCT works by recording ultra-high-resolution projections at several different angles that are used to reconstruct a three-dimensional depiction of the sample (73). Post-processing software (using watershed-based segmentation algorithms (74)) allow quantitative analysis of internal void pathways and void/pore sizes from the projections and three-dimensional depiction obtained.  
Wong and D’Sa et al. used NanoXCT to evaluate the internal structures of several pharmaceutical particles including (2-hydroxypropyl)-beta-cyclodextrin (HβCD), poly (lactic-co-glycolic) acid (PLGA) micro particles, and spray dried smooth and nanomatrix bovine serum albumin (BSA), lipid-based carriers, and mannitol particles (54). Operating in Zernike phase contrast and large field of view or high resolution mode, the technique allowed visualization of internal features larger than 170 nm and 50 nm, respectively. After post image analysis, 3D visualization and quantification of internal void volumes was 
obtainable for HβCD, PLGA, spray-dried mannitol and smooth BSA particles (Figure 4). NanoXCT provides another insightful analytical technique to measure particle internal morphology that can complement previously used techniques such as FIB, TEM, and confocal microscopy. Furthermore, the sample preparation for NanoXCT measurement is less operator time intensive than current sample preparation methods for FIB and TEM analysis.   
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 F I G U R E  4  
NanoXCT (A - C) cross sectional and (D) 3-Dimensional images of a single porous HβCD 
particle. Images obtained from NanoXCT allow clear visualization of the internal 
porosity of the particle (Reprinted from Pharmaceutical Research, Wong J, D’Sa D, Foley M, 
Chan JGY, Chan H-K, NanoXCT: A Novel Technique to Probe the Internal Architecture of 
Pharmaceutical Particles, 1-10, 2014, with permission from Springer.) 
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5. METHODS TO EVALUATE PARTICLE PHYSICAL AND CHEMICAL STABILITY 
IN PROPELLANT  
Measuring particle properties prior to formulation are vital for bulk suspension stability; however, measuring the stability of the particle in formulation is another equally major concern when developing a suspension-based pMDI. Many factors within a formulation that can affect particle stability include, but are not limited to, the choice of propellant or mixture of propellants, co-solvents, and excipients. Furthermore, it is required by the FDA that drug chemical and physical properties and drug-excipient compatibility in the formulation must be fully understood. Thus, it is vital to be able to measure both physical and chemical stability of drug particles in the presence of propellant and any other components present within the formulation. Techniques discussed in this section can be utilized to evaluate particle degradation, solubility, size shifts, crystallization, and excipient compatibility.  
5.1  Cycling and Storage Studies 
The most common techniques to study particle stability in pMDIs are to submit the formulation to extended storage, stressed conditions, and cycling studies. Engaging in stressed or cycling studies, pMDIs are usually stored for extended periods of times, ranging from months to years, at various temperatures and humidities (i.e. 40°C/75%RH, 25°C/60%RH). The elevated conditions exert greater stress on the product than expected to occur during commercial storage and is expected to induce or expedite particle destabilization, via degradation and morphological changes. During these studies, pMDIs 
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can be evaluated at any time point using a variety of aerosol testing methods. Delivered dose uniformity (DDU) experiments can be employed to evaluate changes in the delivered dose after storage and cascade impactors can convey particle size changes due to storage conditions. Additionally, individual particles that are collected by the filter in DDU analysis and collection plates used in cascade impactors can be retrieved and analyzed using any of the techniques listed in Table 1 (granted the required amount needed for analysis can be acquired). For more efficient particle recovery, an alternative method may be used, which involves chilling the pMDI with liquid nitrogen (to liquefy the propellant and depressurize the pMDI), removing the valve using a cutting tool, and evaporating the propellant to retain all particles from the formulation. A drawback of this technique is that particle morphological changes may be an artefact of the recovery process, since a large drop in temperature may induce significant particle changes. For example, if the particles have an appreciable solubility in the formulation, chilling and evaporating the propellant will result in precipitation of the dissolved material. Thus, another important particle property to evaluate is solubility, since any solubility in the propellant will affect particle morphology. 
5.2  Solubility  
Particle solubility is a key factor in formulation stability. Partial solubility of suspended particles can pose several concerns including particle size shifts, crystallization, and increased degradation. Several techniques and improvements have been published to evaluate particle solubility in pMDIs. In the work performed by Dalby et al. a glass vial was crimped with a continuous valve and filled with a suspension of the drug particle of interest and propellant. The formulations were stored in an incubator and solubility samples were 
43 
obtained by transferring the suspension through a 0.22 µm filter sandwiched between stainless-steel support screens to collect only fully dissolved material in another clean glass vial (75). Drug amounts were collected by purging the propellant from the receiving vial (by venting the vapor only), and solubility values were determined via UV spectroscopy. This technique was also used to evaluate the effect of water ingress on drug solubility (76).  
Traini et al. improved upon the technique through the  development of a modified crimpable apparatus, in which a 0.1 µm stainless steel filter frit was inserted between a primary and secondary casing (Figure 5A) (77). Drug particles were filled in the secondary casing, and the entire apparatus was sealed, crimped with a valve, and filled with propellant (Figure 5B). Samples were collected using a twin stage impinger containing solvent and solubility values were quantified using HPLC. The modified apparatus limited experimental errors associated with leaks during external filtration and allowed for the ability to conduct direct aerosol testing of formulations in which a fully drug-saturated propellant is present.  
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 F I G U R E  5  
Solubility apparatus concept developed by Traini et al (A) fabricated primary and 
secondary casing and 0.1 µm filter shown (B) cross sectional view of the apparatus 
fully assembled 
Additionally, Gupta and Myrdal developed a direct on-line reverse phase HPLC method for determining solubility in pMDIs (78). The method involved directly injecting material from a suspension-based pMDI into the manual needle injector port of an HPLC, using an adapter and filter (necessary to filter out the non-dissolved particles). This technique removes variability, due to sample collection, by injecting the sample directly into the HPLC and is thus a more robust method to obtain solubility in propellant. Further improvement on the method presented by Gupta and Myrdal could involve direct injection of the apparatus used by Traini et al. to also limit variability associated with leaks during external filtration. It is noted that this technique requires an appropriate sized sample loop based on the drug solubility and required dilution (if necessary). None-the-less, several techniques are available for the accurate determination of particle solubility in propellants.  
45 
5.3  In-Situ Optical Particle Sizing 
Many particle sizing measurements currently used commercially are conducted using bulk powder or pMDI actuations (cascade impactors). An alternative technique, developed by 
Jones et al. allows in-situ non-destructive particle sizing within a propellant medium. The technique employs a laser diffraction particle size analysis dispersion system and a pressure cell fitted with borosilicate glass windows for measurement. An HFA-based suspension was recirculated through the cell and particle size was measured using a Mastersizer X (Malvern Instruments) (79). Particle size measurements were found to be dependent on the re-circulation rate, since a higher re-circulation rate would create greater shear and break apart floccules present within the suspension, resulting in a primary particle size measurement. Results obtained using this technique showed linear correlation with impaction results from a twin-stage impinger. Although this technique is unlikely to replace impaction particle sizing for aerosols, it can provide important in-process monitoring of particle size during pMDI filling productions. Additionally, a self-contained apparatus may be used to directly evaluate real-time changes in particle size in formulation, or assess changes in particle size after prolonged storage at various time points, without the need for destructive sample acquisition. Other techniques that may also be employed using a similar pressure cell to conduct in-line in-situ particle sizing include using phase doppler anemometry (80, 81) or acoustic/ultrasonic attenuation spectrometry (82, 83).  
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5.4  Isothermal Microcalorimetry 
Isothermal microcalorimetry is a non-destructive technique that uses a precisely temperature controlled (±0.001°C) heat sink in contact with a reference and sample ampoule, to measure any heat change evolved from the sample (84). Any change in heat from the sample (physical or chemical reaction) will produce a temperature gradient across the ultra-sensitive thermoelectric sensors contained within the instrumentation and result in a voltage difference that can be converted to obtain heat flows. The sensitivity of isothermal microcalorimetric instruments such as the Thermal Activity Monitor III (TA Instruments), which has the ability to measure heat change on the nano-watt scale, provides the ability to measure very small changes in a formulation that may occur due to solubility, crystallization, particle size growth, or drug degradation. 
Recent advances in applications of isothermal microcalorimetry to study pMDIs include using model propellant (2H, 3H Perfluoropentane) to evaluate the behavior of spray dried particles when exposed to propellant. Ooi et al. evaluated crystallization kinetics of spray dried beclomethasone dipropionate (BDP) and wetting properties of spray dried salbutamol sulfate particles as a function of 2H, 3H Perfluoropentane (HPFP) concentration titrated into the sample cell during measurement. Using model propellant, they were able to measure the heat evolved from wetting and crystallization of BDP. The BDP crystallized into a clathrate when exposed to the HPFP and comparable crystalline particles were recovered from spray dried BDP particles prepared in HFA 227 (68). The ability to evaluate particles with a model propellant provides a more direct technique to measure crystallization and other physiochemical effects expected to occur for particles suspended 
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in propellant. A further improvement on this technique would be the ability to titrate HFA 134a or HFA 227 while maintaining the entire system under pressure.  
A different approach to titration of a model propellant is analyzing samples in which particles are already suspended in a propellant medium. A newly developed technique by 
D’Sa et al. employing modified pressure rated measurement ampoules (Figure 6) (≤ 10 bars) allows direct evaluation of particle stability in HFA propellants with isothermal microcalorimetry (70). In this work, presented in Chapter 6, spray dried BDP particles suspended in HFA 134a were found to rapidly crystalize to a clathrate, consistent with results obtained by Ooi et al. in model propellant. In another publication, pressurized isothermal microcalorimetry was shown to be effective in evaluating the physical stability of drug particles co-spray dried with various excipients and exposed to variable water contents (Figure 7) (69). Furthermore, the technique was employed to study the degradation of aspirin in particles co-formulated with hydroxypropyl-beta-cyclodextrin (prepared by spray drying, freeze drying, and spray-freeze drying) and suspended in HFA 134a; and the effect of water on the stability (~3 weeks) of spray dried formoterol fumarate particle suspended in HFA 227 at 35°C (71). The ability to measure the heat kinetics of particle change in a propellant based sample may allow direct measurement of drug degradation profiles at various temperatures (including expected storage temperatures). Although pressurized isothermal microcalorimetry can measure a propellant-based sample directly, a major drawback is the method’s non-specificity. Isothermal microcalorimetry measures the total change in heat evolved from a sample and is unable to differentiate whether the measured heat is due to crystallization, dissolution, 
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degradation or an accumulation of instabilities. Therefore, it is important to conduct further analysis on the samples (i.e. SEM, XRPD, HPLC/UV spectroscopy) to verify the cause of heat change.  
 
 F I G U R E  6  
Modified pressure rated ampoule for TAM measurement; (A) an appropriate O-ring is 
used on the cap to ensure a good seal; (B) paraffin is applied below the O-ring to coat 
and fill the O-ring groove to assist in a better seal; (C) image of the actual ampoule 
(Reprinted from Pharmaceutical Research, D’Sa D, Lechuga-Ballesteros D, Chan H-K, 31 (10), 
Isothermal Microcalorimetry of Pressurized Systems I: A Rapid Method to Evaluate 
Pressurized Metered Dose Inhaler Formulations, 2716-2723, 2014, with permission from 
Springer.) 
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 F I G U R E  7  
(A) TAM measured exotherm of spray dried BDP particles when suspended in HFA 134a 
(B) SEM images of spray dried BDP prior to suspension with HFA 134a (C) SEM images 
confirming crystallization of spray dried BDP, as measured by TAM. (Reprinted from 
Pharmaceutical Research, D’Sa D, Lechuga-Ballesteros D, Chan H-K, 31 (10), Isothermal 
Microcalorimetry of Pressurized Systems I: A Rapid Method to Evaluate Pressurized Metered 
Dose Inhaler Formulations, 2716-2723, 2014, with permission from Springer.) 
6. SUMMARY 
Several techniques reviewed within this article are useful in evaluating bulk and individual particle stability both prior to, during, and post formulation with propellants. Major advancements in this field are likely to be centered on the ability to measure particles and their properties in the expected formulation environment and the ability to accurately 
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differentiate between such properties at the nano scale. Already some of these advancements are present in the newer techniques reviewed, such as pressurized isothermal microcalorimetry, in-situ optical particle sizing, and nano x-ray computer tomography. Recent development of a pressurized AFM to topographically image material in supercritical liquid carbon dioxide, also suggests that direct measurement of particle topography and particle interactions in HFAs are probable. Improvement of techniques or modification of the current instrumentation to allow direct identification and quantification of drug degradants and solubility in formulation without the need for sample acquisition would also be beneficial for pMDI formulation development and optimization. 
Additionally, the interest in engineered nano-sized particles for inhalation will further challenge development of applicable analytical techniques. Instrument limitations will be pushed to produce analytical techniques that can accurately differentiate between various particle properties of nano-sized particles.  
Although there is a large arsenal of analytical techniques available to pulmonary formulation scientists today, there is still a need for improvement and innovation of techniques that will not only provide scientists with the ability to measure and analyze formulations quicker, but also more accurately as they pertain directly to the actual system of interest.  
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CHAPTER 2 
 
ATTACHMENT OF MICRO- AND NANO-PARTICLES ON TIPLESS CANTILEVERS FOR COLLOIDAL PROBE MICROSCOPY 
 
 
 
 
This chapter has been published in Journal of Colloid and Interface Science, 2014; 426:190-198, with the title ‘Attachment of Micro- and Nano-Particles on Tipless Cantilevers for Colloidal Probe Microscopy.’ Authors: D’Sa D, Chan HK, Chrzanowski W. 
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1. ABSTRACT 
Purpose 
Current colloidal probe preparation techniques face several challenges in the production of 
functional probes using particles ≤ 5 µm. Challenges include: glue encapsulated particles, glue altered particle properties, improper particle or agglomerate attachment, and lengthy procedures. We present a method to rapidly and reproducibly produce functional micro and nano-colloidal probes.  
Experimental 
Using a six-step procedure, cantilevers mounted on a custom designed 45° holder were used to approach and obtain a minimal amount of epoxy resin (viscosity of ~ 100 cP) followed by a single micron/nano particle on the apex of a tipless cantilever. The epoxy and particles were prepared on individual glass slides and subsequently affixed to a 10x or 40x optical microscope lens using another custom designed holder. Scanning electron microscopy and comparative glue-colloidal probe measurements were used to confirm colloidal probe functionality.  
Results 
The method presented allowed rapid and reproducible production of functional colloidal probes (80% success). Single nano-particles were prominently affixed to the apex of the cantilever, unaffected by the epoxy. Nano-colloidal probes were used to conduct 
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topographical, instantaneous force, and adhesive force mapping measurements in dry and liquid media conveying their versatility and functionality in studying nano-colloidal systems.  
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2. INTRODUCTION 
The atomic force microscope (AFM), developed by Binnig, Quate and Gerber (1) upon the principles of the scanning tunneling microscope and stylus profilometer, has become an essential technique for imaging the topography of surfaces at an atomic level and obtaining force-vs-distance measurements in both air and liquid media (2). Colloidal probe microscopy is a powerful AFM tool (3) which uses a cantilever with a spherical particle attached at the apex – instead of a traditional sharp pyramidal or conical tip – to study nano-scale forces between individual colloid particles. Furthermore, the colloidal probe technique can also be used to study the tangential forces present between particles and the elasticity of materials (4-10). Particle interactions are critical in understanding the fundamental forces that are present in several colloidal systems including paints, paper, soil, clays, pharmaceutical drug particles, food applications and (in some circumstances) cells (11-15). The forces measured through colloidal probe microscopy can provide insight into binding energies, adhesive properties, and in pharmaceuticals can also be used to understand formulation stability and drug particle interactions.  
Prefabricated colloidal probes using gold, borosilicate glass, silicon dioxide, and polystyrene spheres are commercially available; however, it is more applicable to use probes produced from materials present in the studied colloidal system. In principle, any material glued to an AFM cantilever can be used; however material in the form of spherical particles are preferred for practical reasons and for easy comparison to theoretical models, such as the JKR (16) and DMT (17) models (18). To study actual particle and particle-
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material forces present within a specific colloidal system of choice, one must be able to properly attach a colloid particle to the apex of a cantilever.  
Previously published colloidal preparation methods proven successful for attachment of large micron particles (> 10 µm) include using: commercial micromanipulators to obtain glue (Loctite) and silica spheres on a cantilever (19); thin copper wires (~ 40 µm diameter) to position both the glue (Epikote 1004) and silica particle near the apex of the cantilever under an optical microscope (20); and physically sintering silica or glass beads into a cantilever (21, 22). These techniques are not transferrable with ≤ 5 µm particles especially of pharmaceutical or biological value due to the inability to physically sinter and accurately manipulate such particles using 40 µm sized wires.  
Other published methods that are capable of attaching smaller particles (~ 5 µm - 10 µm) – although with several limitations – include using the AFM (23, 24) or using an angled cantilever holder in conjunction with an optical microscope (25) to manipulate cantilevers during the process. AFM methods require the use of multiple cantilevers to prepare a single probe. These methods are characterized by long preparation times due to cantilever alignment procedures and result in the attachment of multiple particles due to the inability to locate a particle of interest without completing an AFM scan. Manipulation using an angled cantilever holder is currently the most functional method used by several others pursuing colloidal probe microscopy in pharmaceutical and biological applications (26-29). This method, developed by Preuss and Butt in 1998, requires attachment of a cantilever on a 30° angle holder to approach epoxy (Epikote 1004 Shell) and particles affixed to a glass 
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slide in the focal plane of an optical microscope. To be workable, the epoxy must be heated above 50°C using an aluminum strip adhered onto a cover slide. Common and significant difficulties faced when attempting to attach ≤ 3 µm sized particles using this and previous methods discussed include:  
1. Complete particle encapsulation by the glue. 2. Difficulty in reproducibly attaching a particle at the apex of the cantilever to maximize functionality.  3. Difficulty to attach a single particle. 4. The requirement to heat the stage, which may induce changes in material properties.   Here we report a method, evaluating key material set up and technique parameters, to addresses these limitations and reproducibly prepare submicron and nano-colloidal probes that can be used to evaluate pharmaceutical and biological submicron-colloidal systems in dry and liquid media.  
  
65 
3. EXPERIMENTAL SECTION 
3.1   Materials  
Porous phospholipid-based particles, used to prepare all colloidal probes and sample substrates, were produced via a previously published spray-drying method of an emulsion formulation (containing DSPC, CaCl2, PFOB, and deionized water) (30, 31). Particles were sized using a Sympatec HELOS (Clausthal-Zellerfeld, Germany) equipped with an R1 lens and Aspiros unit and ranged from sub-micron to 5 µm, with an optical mean diameter of 2 µm. Veeco Model NP-O10 (levers A-D) tipless probes (Veeco, Plainview, NY, USA) and a Hardman Double-Bubble Epoxy (Royal Adhesives & Sealants, Wilmington, CA, USA), a two-component structural adhesives provided generously in the form of sample sachets, were used in colloidal probe preparation. During method optimization several Hardman epoxies varying in viscosities were evaluated including Double-Bubble products: BLACK regular setting (3,700 cPs), GREEN water-clear transparent (14,000 cPs), and RED fast setting (40,000 cPs). Viscosity values were provided as material properties by the manufacturer (Hardman). Previously used epoxies (Epikote 1004 and Epotek 377) were not used in this study as a comparison since they required heating of the stage for application, which can result in physical or chemical alterations to the particles during probe preparation. An Olympus CX41 optical microscope with 10x and 40x objectives was used to manipulate and load colloidal probes. 
66 
 F I G U R E  1  
Custom designed probe holder used to position the probe cantilevers at an angle of 45° 
during colloidal preparation. The holder is attached to a glass slide for easy 
functionality with an optical microscope. Inset: close up view of AFM cantilever 
Custom designed cantilever and glass slide holders (Figure 1) were developed using AutoCAD software (Autodesk Inventor Professional, San Francisco CA, USA) and produced with a Stratasys 3-Dimensional Elite Printer (Tasman Machinery, Cheltenham, VIC, Australia). All holders were made of an ABS thermoplastic polymer (P430). The cantilever holder was attached to a stock microscope slide for easy manipulation (Figure 1). 
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3.2   Production of Glass Slide with Particles  
Particle samples were prepared by dusting particles using a spatula on a clean glass slide or slide coverslip from a distance of approximately five centimeters. The glass slide/coverslip was then shaken and tapped on the bench top to further aid in breaking up agglomerates and removing unattached particles. A minimal amount of sample should be used to limit the chances of agglomerates pending particle electrostatics. 
Another method of preparing the particle slides, involved smearing them across the slide/coverslip using a clean spatula. The smearing action dragged agglomerates across the slide/coverslip producing individually attached particles. Both methods are sufficient in preparing glass slides or coverslips that contain single particles even though agglomerates will still be present. These methods are sufficient for loosely attaching single particles of up to 10 µm onto the glass slide even when inverted. Glass slides should be thoroughly wiped with lint-free kim-wipes to limit accidental attachment of dust or fine glass particles to AFM cantilevers.  
3.3  Production of Glass Slide with Epoxy 
Equal amounts of the two component epoxy were expelled onto a clean glass slide and mixed thoroughly using a sterile pipette. A small amount of the mixed epoxy was smeared onto another clean glass slide to prepare the epoxy slide. It is important to keep the height of the epoxy minimal (a very thin smeared layer is sufficient). Ideally one should be able to focus on the epoxy and the glass slide simultaneously. A clean tool or slow stream of 
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nitrogen can be used to further spread the epoxy on the ‘epoxy slide’ to achieve a thin epoxy layer of minimal height. 
3.4  Fabrication of Colloidal Probe  
The six step procedure shown in Figure 2 was implemented as follows:   Using double-sided sticky tape, a tipless cantilever was first positioned on the edge of a custom designed 45° angle cantilever holder (Figure 2 #1) and a prepared epoxy slide was attached to a custom designed microscope slide holder (Figure 2 #2). During method optimization, other angled holders including 30°, 40°, 50°, and 60° were also tested. The height of the glass slide holder was adjusted by sliding it up or down the microscope lens casing to focus on the particles or epoxy (Figure 2 #3). A re-usable adhesive such as Blu-Tack® was used on one edge to allow temporary attachment and easy exchange of particle and epoxy slides. The epoxy slide was attached (epoxy side facing down) so that half of the microscope field of view was glue and the other half blank slide (Figure 2 #5). The cantilever mounted on the 45° holder (Figure 2 #4) was then brought into contact with the edge of the epoxy layer and dragged in the XY plane out of the epoxy across the clean glass slide region to minimize the amount of and localize the epoxy onto the cantilever apex (Figure 2 #5). Once glue was acquired on the cantilever, the epoxy slide was replaced with the particle slide and the slide holder readjusted to bring the particles into focus finding a single particle of interest (Figure 2 #6). The cantilever was then raised again using the microscope stage to approach a single visible particle. Depending on the size of the particle, the cantilever was either brought into contact with the particle of interest from directly 
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below (> 3 µm) (Figure 3A) or by contacting the glass slide in front of the particle and dragging backwards to obtain attachment at the apex of the cantilever (< 3 µm) (Figure 3B). Glue only colloidal probes were also produced for comparative studies. A video depicting this method is included in the supplementary information. 
Method efficiency was determined by producing 10 probes in succession each day (3 days) for each probe type (n = 30) and visually determining the number of functional probes via scanning electron microscopy (SEM). Functional probes were defined as a probe containing a single particle located at the apex of the cantilever not largely affected by glue. Probes containing large amounts of glue or particles nearly enveloped by glue were not considered functional. Additionally, the reflective side of the cantilever should be free of glue.  
3.5  Electron Microscopy  
Scanning electron microscopy (SEM) images were carried out using Ultra and EVO Qemscan (Zeiss, Carl Zeiss Microscopy, Jena, Germany) microscopes, operating at either 5 keV or 10 keV and a working distance of 5 - 15 mm. Samples were not coated and charge compensation mechanisms were used when available, which included the ability to insert a gas injecting needle near the sample while imaging to reduce charging effects.  
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 F I G U R E  2  
Steps taken to successfully attach a single colloidal particle on the apex of a tipless 
cantilever to produce a functional colloidal probe; (1) Tipless cantilever is attached to 
holder; (2) Slide with epoxy is attached to appropriate holder (epoxy side away from 
the holder); (3) Glass slide holder slipped onto microscope lens by sliding the glass 
slide holder over the microscope lens and epoxy brought into focus; (4) Cantilever 
holder slowly lifted to bring cantilever into contact with epoxy; (5) Cantilever is 
brought into contact with epoxy and slowly dragged out of epoxy to obtain a minute 
amount of epoxy localized at the apex of cantilever; (6) Replace epoxy slide with colloid 
particle slide and repeat steps 3-5 to acquire a single particle on the apex of the 
cantilever 
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 F I G U R E  3  
 Depiction of the two techniques for approaching a particle of interest with a probe 
already containing glue (view from microscope lens); (A) Direct approach from 
underneath the particle (> 3 µm); (B) Contacting the glass slide in front of particle and 
dragging (< 3 µm) (C) Contact of the particle at the apex of the cantilever resulting 
from both approach techniques 
3.6  AFM Measurements 
A Molecular Force Probe MFP-3D-Bio (Asylum Research, Santa Barbara CA, USA) was used for all colloidal probe measurements. Prior to data acquisition, spring constants for all probes were measured thermally using the resonant frequency of the thermal noise spectrum and probe sensitivity was calculated from the slope of the contact region in the force vs. separation curve. Force measurements in liquid and air were conducted using an approach/retract rate of 100 nm/s and a trigger of 20 nm deflection. For each colloidal 
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probe type (glue, micron, nano), a total of 30 force data points were measured across three different substrate particles (n = 10/particle). The same colloidal probes were used for both liquid and air measurements. Topographical images (air and liquid) were obtained using contact mode with a 512 × 512 resolution and a scan rate of 1 Hz.  
All liquid measurements were conducted in a model propellant (2H, 3H Perfluoropentane). The model propellant was contained during measurement using a liquid cell (Model CCELL, Asylum Research, Santa Barbara CA, USA) and equilibrated for at least 30 minutes to prevent thermal drift during the measurement (32). Statistical significance was evaluated with a 95% confidence level (P < 0.05) using a two-tailed T test. 
4. RESULTS AND DISCUSSION 
4.1   Key Material and Technique Improvements 
The materials and set up presented in this study to produce colloidal probes results in a more reliable and reproducible method. Key materials promoting easier colloidal probe production include the use of: tipless cantilevers, a 45° angle cantilever holder and a room temperature workable epoxy with a viscosity of 14,000 cPs at 25°C.  
Tipless AFM cantilevers are required to ensure that the attached particle is the most prominent feature on the probe, especially when attaching submicron particles (33). Attaching a particle to the very tip of a traditional conical or pyramidal tip will be less accurate and the sharp probing tip of the cantilever may damage the particle during probe 
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production or force-volume measurements (ex. may puncture or crack particle). The flat surface of the tipless cantilever requires less operator precision and ensures that the particle is the only protruding feature of the probe. Since most AFM tipless probes will have two cantilevers present (one longer than the other) (Figure 1 inset); if the shorter cantilever is desired the longer one must be broken using a pair of tweezers under the microscope to allow unimpeded access during the preparation process. 
 F I G U R E  4  
Non-functional colloidal probes prepared by: [particles highlighted] (A) using an 
angled cantilever holder of 60°; (B) using an angled cantilever holder of 30°; (C) use of 
a higher viscosity glue (40000 cPs at 25°C); (D) use of a lower viscosity glue (3700 cPs 
at 25°C) 
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Maintaining the cantilever at an angle of 45° (Figure 1) is critical to reduce the amount of glue on the cantilever tip and increase particle attachment precision. Several cantilever holder angles were tested during method development ranging from 30° to 60° (30°, 40°, 45°, 50°, 60°) and it was found that at an angle of 45°, the apex of the cantilever comes into focus first facilitating it also as the first point of contact during the approach toward the glue and subsequently particle prepared slides (Figure 2 #4/#6). The apexes of cantilevers attached to higher angled holders were more difficult to focus on under the microscope and as a result glue was frequently acquired on the reflective side (Figure 4A), which has negative implications during measurement acquisition. Lower angled holders allowed glue to spread across a larger area of the cantilever resulting in multiple particle or particle attachment at a further distance from the cantilever apex (Figure 4B). Probes containing multiple particles produced erroneous results and inaccurate topographies such as false features or multiple images of the same feature due to the deflection of the cantilever caused by the interaction of more than one colloid particle (Figure 5). The magnitude and type of these errors is related to the scan size, direction and distance between the colloid particles that can sense the substrate simultaneously or sequentially. Use of the higher (60°) and lower (30°) angled holders greatly reduced the success of functional micron colloidal probe preparation on average to roughly 10-20% (80% using the 45° holder).   
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 F I G U R E  5  
Erroneous AFM topographical image of a single particle located on the substrate, 
duplicated as a result of cantilever deflection caused by sequential sensing of the 
particle by two colloid particles attached to the probe  
Another key material improvement that facilitates faster colloidal probe preparation is the use of an epoxy that is workable and curable at room temperature. The heating step required to ‘melt’ previously used epoxies (e.g. Epikote 1004 / Epotek 377) to a workable form and/or the UV exposure step to cure the epoxy were the biggest time-limiting steps of previously published methods and can result in physical or chemical damage to the particles. Furthermore, prior to each probe production the epoxy must be reheated or maintained at a specific temperature. The Hardman epoxy used in this study does not require a heating step and because the epoxy has a 2 hour working time (before it hardens) there is a lengthy window to prepare multiple probes after the initial quick setup. Thus, the 
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extended working time and room temperature workability properties of the epoxy results in a faster colloidal probe preparation method – on average 10 probes within 30 minutes. 
The most important attribute of the epoxy was its viscosity (14000 cPs at 25°C), which facilitated easy manipulation to obtain a minute amount of epoxy on the cantilever apex. Epoxies that were greatly more or less viscous resulted in less accurate and nonfunctional colloidal probes. Higher viscosities produced large glue droplets on the cantilever (Figure 4C), while lower viscosities spread across the cantilever allowing particle attachment further from the cantilever apex (Figure 4D). During epoxy acquisition, the cantilever should be dragged away from the epoxy and not forward through the epoxy to prevent buckling of the cantilever and accumulation of epoxy on the reflective side. This technique in addition to the viscosity of the epoxy facilitates the localization of a tiny amount of epoxy on the apex of the cantilever. If a large amount of epoxy is still visible on the cantilever tip, repeating the approach and drag techniques will rectify the issue. The minimal amount of glue is beneficial to reduce the effect of glue on the particle interactions, which can have a large effect on the mechanical properties of porous or rugose particles and engulf submicron particles. Glue encompassed probes will produce inaccurate results as discussed later.  
 In addition to the improved materials, the techniques used to attach variably sized particles to the colloidal probes presented in Figure 3 are vital in improving method 
efficiency. For particles ≥ 3 µm it was sufficient to approach the particle from directly below, positioning the tip so the particle is located at the apex of the cantilever when the 
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apex is in focus (essentially in contact with the particle/slide) and then withdraw. Because of the minimal amount of glue on the cantilever, approaching the particle from directly below will not result in encapsulation of the particle by the glue. This is evident from the SEM images of probes produced using this method (Figure 6 A/B).   
A different method of approach was more accurate and reproducible for particles smaller than 3 µm. Using the 40x objective and colloidal particles prepared on a coverslip, we were able to focus on and acquire submicron and nano-sized particles more efficiently. Once a particle of interest was located, the cantilever was brought into contact with the glass slide in front of the particle and then slowly dragged backward (on the XY plane) until the cantilever apex contacted the particle. The 45° angle of the cantilever promotes attachment of the particle at the apex of the cantilever during the dragging motion (Figure 6 C-F). The actual lateral location of the particle on the apex of the cantilever can vary based on the operator’s visual acuity and manipulation skills to ensure that the particle of interest is maintained at the central point of the cantilever during the dragging technique, since precise movements with the microscope stage can be difficult to control. Thus, training in this technique will improve method efficiency. Variability in the lateral placement of the particle may result in complications during data comparison of multiple probes and should be considered during measurement acquisition. Modifying the tilt and set up of the AFM instrument probe holder head is vital to ensure that the affixed nano-particle is the first point of contact during measurement and to mitigate effects of laterally variable prepared nano-colloidal probes.  
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4.2  Characterization of Colloidal Probes 
Scanning electron microscopy of the probes prior and post measurement is necessary to ensure particles are attached to the cantilever tip sufficiently and don’t undergo any physical changes during the measurement. Coating of the probes for imaging should be avoided, since such modifications will negate the efforts of the interaction forces in question. The inability to coat the samples prior to SEM imaging can result in large charging effects during imaging. This can be mitigated using environmental/low-vacuum SEM or charge-compensation mechanisms if available.  
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 F I G U R E  6  
SEM images of prepared colloidal probes; (A-B) Single 2 µm particles affixed to the 
apex of the cantilever with minimal glue interaction (C-E) Single submicron and nano 
colloidal particles affixed to the apex of the cantilever, with minimal glue interaction. 
(F) Zoom in of same probe shown in ‘E’ 
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The spring constant and sensitivity of the modified cantilever must be measured prior to acquisition or analysis of any quantitative data with the colloidal probes. Spring constants can be measured using built in instrument thermal resonance calculations, while probe sensitivity is more reliably calculated from the slope of a force/deflection vs. z-distance curve obtained by approaching and indenting an “infinitely hard” surface (i.e. freshly cleaved mica), usually acquired at the end of all measurements since the probe can be damaged during the process. It is erroneous to use the manufacturer’s spring constant and sensitivity as the default, since attachment of a particle to the cantilever will alter these values. Table 1 shows the effect of particle attachment on the spring constants for the probes used in sections 4.3 and 4.3.1 to obtain topographical and force measurements. Table 1 also conveys that changes in the spring constant are directly related to the mass attached. 
T A B L E  1  
Spring constants for each of the colloidal probes used in this paper to obtain 
topographical images and force measurements 
Probe Type Spring Constant Blank Tipless Probe 60.00 pN/nm Nano-Colloidal Probe 66.46 pN/nm Micro-Colloidal Probe 78.59 pN/nm Glue-Colloidal Probe 133.31 pN/nm 
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4.3  Colloidal Probe Functionality  
A common concern during colloidal probe preparation is the impact of the epoxy on the accuracy of the measurement. To ensure that prepared colloidal probes were unaffected by the epoxy, we compared glue-only ‘colloidal’ probes to functional micro and nano colloidal probes. Topographical images obtained using the glue-only probe produced a smoother surface with larger features (Figure 7C) compared to the more detailed and rugose surface evident when scanning the same sample material with a functional micron or nano colloidal probe (Figure 7 A/ B). It is important to note that colloidal probes will not provide ‘true’ topographies (as shown via SEM (Figure 7D)) because of the large particle curvature of the probing area in comparison to a standard tip. For detailed qualitative and quantitative topography imaging, a standard conical or pyramidal tip is highly preferred. Topographical images were simply presented to show the effects of improperly prepared probes. Topography in CPM is typically used only to determine image height (affecting force distance parameters) and to find a particle/material of interest to evaluate interaction forces. 
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 F I G U R E  7  
Topographical images were obtained to show the drastic differences between 
functional probes and a glue only probe. The images were obtained by scanning the 
same particle substrate using a (A) 2 - 3 µm sized colloidal probe (B) < 1 µm sized 
colloidal probe and (C) glue only colloidal probe;  (D) SEM image of the substrate 
particles shows the true particle topography 
The main purpose of CPM is to study the forces present between the colloid particle and a particle/material of interest once located. To convey the differences between the nano-scale forces measured by glue-only probes and functional micro and nano colloidal probes, simple force measurements were conducted on particle prepared substrates (Figure 8A). Force results convey that there was significant differences for snap-in and max-pull forces between the glue-only and functional (micro and nano) probes, which supports that micro and nano prepared colloidal probes were not affected by the epoxy. The representations of these measured forces are conveyed in a model deflection vs. z-distance curve (Figure 8B). Differences between the micro and nano colloidal probe measured forces are most likely attributed to varying surface morphologies and interaction areas (34, 35). Another key 
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difference between the glue-only probe and functional colloidal probes is the increased variability evident in measurements obtained using the glue-only probe. These large differences in measured forces and data variability suggest that if probes were largely affected by glue they would be easily distinguishable.  
 F I G U R E  8  
(A) Comparison of force values in air obtained from a probe in which the forces were 
dictated by the epoxy used (glue probe) vs. micron and nano colloidal probes prepared 
using the method described within. (n = 20) (B) Standard deflection vs. z-distance 
curve obtained during a normal force measurement using the AFM indicating how the 
force values are determined: ‘max load’ is the maximum compressive force into the 
sample; ‘max pull’ is the maximum adhesive force; ‘snap in’ is the adhesive forces. Note: 
* indicates that data sets were statistically significantly different than the glue-probe 
(p < 0.05) 
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4.3.1  Case Study: Mimicking Pharmaceutical Applications – MDI Formulations 
The colloidal interactions that govern a number of pharmaceutical drug colloidal systems (powders, tablets, liquid suspensions) are vital to formulation stability, storage and drug delivery. For example, drug particle interactions in suspension metered dose inhaler (MDI) formulations (used to deliver a variety of drugs to treat respiratory and systemic diseases) dictate how fast colloid particles separate in a formulation, which can greatly affect drug dosing. 
To ensure colloidal probes prepared with the presented technique are suitable to study various colloidal systems in air and liquid mediums, we conducted force map measurements with colloidal probes made using model MDI phospholipid-based particles in a model propellant medium (2H, 3H Perfluoropentane). First, to confirm that measurements obtained were accurate and not affected by the epoxy, force measurements on particle substrates conducted in liquid propellant were compared for glue only and functional micro and nano probes (Figure 9). Similar to the results obtained for force measurements in air (Figure 9), the snap-in and max-pull forces varied significantly between the glue only and functional (micro and nano) probes. Additionally, the data variability for glue-only probes was significantly greater than that for functional probes. This conveys, that even in liquid, it is easy to differentiate between a properly prepared colloidal probe and one that is largely affected by glue. Forces measured in liquid were significantly lower than those measured with the same probes in air. Furthermore, force values (max-pull and snap-in) measured using micro and nano probes were more similar in 
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liquid (Figure 9) than in air (Figure 8), which may suggest that surface morphology and interaction areas are larger factors in air measurements.  
Once aware of the differences between a functional and non-functional colloidal probe, we used a properly prepared < 1 µm colloidal particle probe to measure the range of nano-scale adhesive forces present between two particles – as expected for those particles suspended in an actual MDI formulation – and plot those forces according to the topography of the substrate particle (Figure 10). Figure 10 conveys that although the topographical images are not fully accurate (due to often irregular and large probe curvature), superimposing a force map onto the coarse topographical image can provide a sufficient depiction of the effect of topography on the forces present between the colloid probe and substrate. Furthermore, it is evident that the colloidal probes prepared using this method are suitable for liquid colloidal measurements and can be used to obtain data on the nano-scale forces between particles that may be vital to pharmaceutical formulation design, development and optimization. 
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 F I G U R E  9  
Comparison of force values obtained from a probe in a liquid medium (HPFP) in which 
the forces were dictated by the epoxy used (glue probe) vs. micron and nano colloidal 
probes prepared using the method described within (n = 20). Note: * indicates that 
data sets were statistically significantly different than the glue-probe (p < 0.05) 
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 F I G U R E  1 0  
Force-volume data obtained using a < 1 µm colloidal probe (prepared using this 
method) across a 1 x 1 µm scan area of a similar particle attached to a substrate in a 
model propellant liquid medium; (A) max-pull adhesive force map; (B) topographical 
map (C) combined 3D depiction of the max-adhesive forces present as a function of 
particle topography 
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5. CONCLUSION 
A 45° angle cantilever holder ensures that the apex of the cantilever is the first point of contact during manipulation and the 14000 cPs viscosity of the epoxy facilitates the localization of a minute droplet of glue on the apex of the cantilever which promotes particle attachment at the apex as well. These key material developments in conjunction with the techniques discussed in this paper address the major limitations of several previous methods and allows accurate, rapid, and reproducible production of functional micron and nano-colloidal probes that are unaffected by the epoxy and can be used to study both dry and liquid submicron-colloidal systems.  
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CHAPTER 3 
 
 
QUANTITATIVE AND QUALITATIVE EXAMINATION OF PARTICLE-PARTICLE INTERACTIONS USING COLLOIDAL PROBE NANOSCOPY 
 
 
 
This chapter has been published in Journal of Visualized Experiments, 2014; 89: e51874-e51874, with the title ‘Quantitative and Qualitative Examination of Particle-Particle 
Interactions using Colloidal Probe Nanoscopy.’ Authors: D’Sa D, Chan HK, Kim HW, Chrzanowski W. 
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1. ABSTRACT 
Colloidal Probe Nanoscopy (CPN), the study of the nano-scale interactive forces between a specifically prepared colloidal probe and any chosen substrate using the Atomic Force Microscope (AFM), can provide key insights into physical interactions present within colloidal systems. Colloidal systems are widely existent in several applications including, pharmaceuticals, foods, paints, papers, soil and minerals, detergents, printing and much more (1-3). Furthermore, colloids can exist in many states such as emulsions, foams and suspensions. Using colloidal probe nanoscopy one can obtain key information on the adhesive properties, binding energies and even gain insight into the physical stability and coagulation kinetics of the colloids present within. Additionally, colloidal probe nanoscopy can be used with biological cells to aid in drug discovery and formulation development. In this paper we describe a method for conducting colloidal probe nanoscopy, discuss key factors that are important to consider during the measurement, and show that both quantitative and qualitative data can be obtained from such measurements.  
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2. INTRODUCTION  
Atomic force microscopy (AFM) is a technique that enables qualitative and quantitative imaging and probing of a material surface (4-6). Traditionally, AFM is used for the evaluation of surface topography, morphology, and structure of multi-phasic materials. AFM has the capability to quantitatively evaluate nano-scale interactions such as charge, attraction, repulsion, and adhesion forces between a specific probe and substrate in both air and liquid mediums (7, 8). The AFM originally developed by Binning, Quate and Gerber (9) uses a probe of known/determined sensitivity and spring constant to approach and/or scan a sample. Due to the physical interactions between the probe and the sample, the cantilever is deflected during contact or proximity and depending on the mode of operation, this deflection can be translated to acquire the topography of the sample or measure forces present between the probe and sample. Modifications to the AFM technique, such as colloidal probe nanoscopy (10), have allowed scientists to directly evaluate the nano-force interactions between two materials present in a colloidal system of interest.  
In colloidal probe nanoscopy, a spherical particle of choice is attached to the apex of a cantilever, replacing the traditional conical and pyramidal tips. A spherical particle is ideal to allow comparison with theoretical models such as the Johnson, Kendal, Roberts (JKR) (11) and Derjaguin, Landau, Verwey, Overbeek (DLVO) (12-14) theories and to minimize the influence of surface roughness on the measurement (15). These theories are used to define the contact mechanics and inter-particle forces expected within a colloidal system. 
96 
The DLVO theory combines the attractive Van der Waal forces and repulsive electrostatic forces (due to electrical double layers) to quantitatively explain the aggregation behaviour of aqueous colloidal systems, while the JKR theory incorporates the effect of contact pressure and adhesion to model elastic contact between two components. Once an appropriate probe is produced, it is used to approach any other material/particle to evaluate the forces between the two components. Using a standard manufactured tip one will be able to measure interactive forces between that tip and a material of choice, but the benefit of using a custom made colloidal probe allows the measurement of forces present between materials present within the studied system. Measurable interactions include: adhesive, attractive, repulsive, charge, and even electrostatic forces present between the particles (16). Additionally, the colloidal probe technique can be used to explore tangential forces present between particles and material elasticity (17, 18). 
The ability to conduct measurements in various media is one of the major advantages of colloidal probe nanoscopy. Ambient conditions, liquid media, or humidity controlled conditions can all be used to mimic environmental conditions of the system studied. The ability to conduct measurements in a liquid environment enables the study of colloidal systems in an environment that it naturally occurs; thus, being able to quantitatively acquire data that is directly translatable to the system in its natural state. For example, particle interactions present within metered dose inhalers (MDIs) can be studied using a model liquid propellant with similar properties to the propellant used in MDIs. The same interactions measured in air would not be representative of the system existent in the inhaler. Furthermore, the liquid medium can be modified to evaluate the effect of moisture 
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ingress, a secondary surfactant, or temperature on the particle interactions in an MDI.  The ability to control temperature can be used to mimic certain steps in the manufacturing of colloidal systems to evaluate how temperature either in the manufacturing of or storage of colloidal systems may have an impact on particle interactions.  
Measurements that can be obtained using colloidal probes include; Topography scanning, individual force-distance curves, force-distance adhesion maps, and dwell force-distance measurements. Key parameters that are measured using the colloidal probe nanoscopy method presented in this paper include the snap-in, max load, and separation energy values. Snap-in is a measurement of the attractive forces, max load the value of the maximum adhesion force, and the separation energy conveys the energy required to withdraw the particle from contact. These values can be measured through instantaneous or dwell force measurements. Two different types of dwell measurements include deflection and indentation. The length and type of dwell measurement can be specifically chosen to mimic specific interactions that are present within a system of interest. An example is using deflection dwell - which holds the samples in contact at a desired deflection value – to evaluate the adhesive bonds that develop in aggregates formed in dispersions. The adhesive bonds formed can be measured as a function of time and can provide insight into the forces required to redisperse the aggregates after prolonged storage. The plethora of data that can be obtained using this method is a testament to the versatility of the method.  
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3. EXPERIMENTAL PROTOCOL 
3.1  Preparing the Colloidal Probe and AFM Substrate 
To prepare colloidal probes, use a method developed previously by the authors (19). In brief, use a 45° angle holder to affix a tipless cantilever at the specific angle of 45° (Figure 1A). Prepare an epoxy slide by smearing a thin layer of epoxy onto a microscope slide. Use a clean spatula or a slow stream of nitrogen to ensure that the layer of epoxy added to the microscope slide is of minimal height. Affix the epoxy slide to a 40x optical zoom microscope lens using a custom designed holder (Figure 1B). Then use the cantilever to approach the epoxy slide and acquire a small amount of epoxy on the cantilever. Repeat 
these steps to also attach a single particle of interest at the apex of the cantilever (Figure 1C). 
Prepare the AFM substrate by affixing colloidal particles onto an AFM coverslip using a thermoplastic mounting adhesive. Heat a 35 mm round cover slip to 120°C, and apply a small amount of the adhesive to the coverslip. The high temperature is necessary to melt the thermoplastic adhesive for application. Then cool, the coverslip to 40°C before dusting the colloidal particles onto the glue. At 40°C the glue is sufficiently set that the particles will not become embedded into the glue, but the glue is sticky enough to ensure that the particles will adhere to the substrate. Further cool the coverslip to room temperature and use a gentle stream of nitrogen to blow off any excess unattached particles. Wash the substrate several times with the liquid medium that will be used for colloidal probe measurements to ensure that all unattached particles are removed from the substrate.  
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 F I G U R E  1  
Depiction of the method used to produce colloidal probes for colloidal probe nanoscopy 
(A) AFM cantilever, attached to a custom designed 45° cantilever holder; (B) 
Epoxy/Particle slide is affixed to a secondary holder that is slid onto the microscope 
lens; (C) The cantilever is slowly raised to acquire epoxy and a particle 
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This is important to reduce the effects of free flowing particles during the measurement which can interact with the cantilever and introduce errors in the results. 
3.2  Mounting the Colloidal Probe, Aligning Laser, and Equilibrating System 
Mount the coverslip with the colloidal particles into the bottom half of a liquid cell, making sure that the O-ring is seated properly to prevent any leaking. Place a hydrophobic transparent sheet onto the microscope stage to guard against any liquid that may leak during the experiment, especially if only using the bottom half of a liquid cell for the measurement, and place the liquid cell onto the microscope stage. For simplicity one can use only the bottom half of a liquid cell, given that the system can be equilibrated adequately. If the liquid evaporates rapidly, the evaporation will negatively impact the results.  
Attach the colloidal probe to the AFM scanning head and assemble onto the AFM. With the AFM instrument software on, use the knobs on the scanning head to bring the cantilever tip into focus. (All procedural steps and measurements were completed using an MFP-3D-Bio AFM with Asylum Research software (Asylum Research, Santa Barbara CA, USA)). To maximize intensity, align the laser onto the tip of the cantilever using the appropriate adjustment knobs on the scanning head.  
Allow the system to equilibrate for 5 - 10 minutes or until the deflection value stabilizes. Use the deflection adjustment knob to bring the deflection to zero or slightly negative. After the system has equilibrated in air, use the AFM software (Thermal Panel in the Master 
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Panel window) to thermally calculate the InvOLS (sensitivity) and spring constant of the colloidal probe. This sensitivity will be temporarily used until the true sensitivity is measured at the completion of the measurement.  
Select either “Cal Spring Constant” or “Cal InvOLS” and then click on “Capture Thermal Data.” Once a prominent peak is apparent, stop capturing data, and click to zoom over the main peak. Click on “Initialize Fit” followed by “Fit Thermal Data,” to obtain the automatically calculated spring constant or InvOLS values.  
Slowly add 2 mL of the liquid medium to the liquid cell using a syringe and ensure that no bubbles are present around the cantilever. Re-align the laser, since the refractive index of the medium has now changed, and once again equilibrate the system allowing the deflection value to stabilize before adjusting the deflection back to zero. If a large temperature difference exists between the environment and liquid, equilibration will take longer. 
3.3  Imaging and Data Acquisition 
Set the initial scan size to 20 µm, scan rate to 1 Hz, scan angle to 90°, set point to 0.2 V and obtain a scan of the sample. Adjust the gain as needed to obtain overlapped trace and retrace curves. Once a particle of interest is found, immediately zoom onto that particle to limit extended probe interactions with the substrate prior to obtaining force volume measurements. Once zoomed in, acquire a sufficient image of a single particle or portion of a single particle. Then switch to the Force Panel in the software. Bring the red position bar 
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to the highest position, set the force distance to 5 µm, scan rate to 0.1 Hz, trigger channel to none and conduct a single force measurement. Make sure the probe does not contact the substrate.  
From the single measurement graph obtained, calculate the virtual deflection line by right clicking on the graph window, and selecting the “Calculate Virtual Def Line” option. This will automatically calculate the virtual deflection and update the value as needed within the software. Change the trigger channel to deflection and set the trigger point to 20 nm. Set the force distance to 1 µm and adjust the scan velocity as desired depending on the measured forces of interest. 
Manually adjust the value for the deflection Inverse Optical Lever Sensitivity (InvOLS) in the Review Force Panel after conducting 2 - 3 consecutive preliminary single force measurements. Conduct a single force measurement, then click on the “Review” button on the Force Panel which opens up a Master Force Panel. Highlight the most recently completed force measurement. Under the “Axis” heading ensure that only “DeflV” is checked. Change the “X-Axis” input field to “Sep” using the dropdown menu and click on “make graph.” Click on the “Parm” tab on the Master Force Panel and adjust the value of “InvOLS” until the contact region of the graph is completely vertical. Then populate this value in the “Defl InvOLS” field located under the Cal sub-tab in the Force tab located on the main Master Panel window. Repeat this 2 - 3 times to ensure that the InvOLS value does not change significantly.  
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Now that all parameters have been set up, ensure that the liquid medium level is still sufficient and that the deflection is still stable. At this time, single force curves or force maps can be obtained. If dwell force measurements are desired, the dwell options can be accessed in the Force Panel.  
3.4  Post-tuning of Sensitivity for Analysis  
After the completion of measurement acquisition, measure the true sensitivity of the colloidal probe. To do this, conduct a force measurement using a relatively large deflection/force with the colloidal probe in the same liquid medium against an “infinitely” hard surface such as mica. Sensitivity was obtained after completion of the experiments because the large deflection/force may damage colloidal probes prepared with porous or fragile colloids. The slope of the contact region is used by the software to automatically calculate the sensitivity (Figure 2). Use this true value of sensitivity during data analysis of all the curves obtained using that particular colloidal probe.  
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 F I G U R E  2  
The sensitivity of the cantilever is the slope of the contact region of a deflection vs. z-
distance curve  
4. REPRESENTATIVE RESULTS 
Liquid colloidal systems are used for several pharmaceutical drug delivery systems. For inhalation drug delivery, a common colloidal system is the suspension pressurized metered dose inhaler (pMDI). Particle interactions present within the pMDI play a vital role in formulation physical stability, storage, and drug delivery uniformity. In this manuscript, inter-particle forces between porous lipid-based particles (~ 2 µm optical mean particle diameter) in a model propellant (2H, 3H Perfluoropentane) were evaluated at room temperature to convey the functionality of and possible errors associated with the presented procedure.  
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 F I G U R E  3  
Properly prepared Colloidal Probes that can be used to conduct the colloidal probe 
measurements 
Figure 3 shows two representative colloidal probes prepared using the lipid-based inhalable particles that can be used for colloidal probe nanoscopy. It is important that a single colloidal particle is affixed to the apex of the cantilever such that it is the most prominent feature and will be the first point of contact during the measurement. This ensures that the interactions measured are solely due to the colloid particle. Attaching multiple particles or particle agglomerates can produce erroneous results (Figure 4) due to multiple cantilever deflections caused by both particles simultaneously sensing the same single particle present on the substrate. Using properly prepared colloidal probes topographical images of a particle substrate such as those shown in Figure 5 can be achieved in a liquid medium.  
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Topography scans using a colloidal probe will be less defined than those obtained using a sharpened conical tip; however, in CPN, the main purpose of a topographical scan is to locate a particle on the substrate that can be used to evaluate the inter-particle interactions. Figure 6 conveys several force curves one may encounter when conducting colloidal probe measurements in a liquid medium. Liquid measurements contain more sources of error during measurement and one should be aware of all sources to appropriately minimize their effect on the accuracy of the measurement (Figure 6A). 
 F I G U R E  4  
The use of a colloidal probe that has multiple particles affixed may result in the 
erroneous duplication of a single particle present on the substrate during the 
topographical scanning of the substrate 
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 F I G U R E  5  
Topography scans obtained using a properly prepared colloidal probe. (A) A large scan 
revealing multiple particles of interest; (B) A more focused scan revealing one major 
particle of interest; (C) A scan focused on the surface of a single particle 
The rapid and sharp peaks evident in the force curve in Figure 6B are indicative of a sudden disturbance to the system during the measurement. This can be attributed to AFM instrument movement or a sudden noise in the background (ex. door slamming, sneezing) which results in a short period of instantaneous and rapid destabilization. In Figure 6C the fluctuation of the baseline in the approach and retraction of the cantilever suggest a problem with the liquid medium. This may occur if the liquid cell is not adequately filled 
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allowing the evaporation of the medium to have a large impact on the stability of the system and measurement. An alternative source of this instability can be from improper equilibration of the cantilever in the liquid medium prior to analysis. The cantilever is sensitive to changes in temperature and actions such as ‘topping off’ the liquid cell require adequate re-equilibration time. Figure 6D depicts a baseline shift during the approach and retract cycle. This clean shift is non-existent during instantaneous force measurements, but is more apparent in dwell force measurements. This drift is an effect of cantilever thermal drift, which can occur for several reasons including: slow evaporation of the liquid medium leading to a change in the temperature of the medium, using a medium that is still equilibrating to the surrounding temperature, or conducting the measurement in an environment that is not ideally controlled. Minimal steady shifts in the temperature of the liquid medium during the measurement produce such drifts. This type of measurement drift is difficult to control for high evaporating liquids, unless a closed liquid cell is used during measurement; however, most AFM analysis software can correct such drifts.  
After all controllable sources of error have been mitigated and the system is appropriately equilibrated, adhesion mapping can be employed to obtain a large statistical body of data across a determined size of the sample. Force mapping can be used independently or in conjunction with topographical scanning to evaluate the effect of topography on particle adhesive forces (Figure 7). Force mapping will provide two major graphs of interest: a topographical map of the sample based on the height at which the cantilever contacts the substrate (Figure 7A) and an adhesion map conveying the max pull force of each individual force curve (Figure 7B). The graph in Figure 7B can also be used to obtain a numerical 
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average and standard deviation of adhesion and snap-in forces, as well as separation energies across the entire sample. These raw data graphs can be viewed as three-dimensional representations of the topography or spread of adhesion measurements across the sample (Figure 7C/D) and overlaying them will produce a three dimensional illustration of the distribution of the adhesion forces as a function of the topography (Figure 7E). This type of data provides critical understanding of the forces present between colloids and how the surface of the colloids further effect interactions.  
 F I G U R E  6  
Force curves obtained with various limitations that one must be aware of. (A) example 
of a good force curve; (B) force curve showing a disturbance either by movement of the 
AFM or by noise present during the measurement; (C) fluctuation due to un-
equilibrated cantilever can lead to unstable approach/retract; (D) thermal drift 
present during a measurement, existent because of slow evaporation leading to 
cooling of the medium or unstable environmental control  
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 F I G U R E  7  
Adhesion force mapping that can be obtained using colloidal probe nanoscopy. (A) 
topographical distribution of the sample surface; b) distribution of max adhesion force 
across the sample. (C/D) 3-dimensional representations of the graphs shown in a and b 
respectively; (E) overlay of the topography and adhesion forces producing a single 
three dimensional illustration of the adhesion forces as a function of topography 
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 F I G U R E  8  
Adhesion forces measured as a function of dwell time using two varying dwell 
measurements (n=30), (◊) indentation (□) deflection; Note: * indicates a significant 
difference between values at the specific time point using a two-tailed T-test with 95% 
confidence (p  < 0.05) 
Additionally dwell force measurements can be used to evaluate the effect of contact mechanics and length of contact on the adhesive forces. Solid lipid particles were used to convey the effect of the dwell on the measured adhesive forces (Figure 8). Figure 8 indicates that adhesive forces increase as a function of time using indentation dwell, while they plateau using deflection dwell. This trend becomes more obvious at longer dwell times (180 seconds).  
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5. DISCUSSION 
Several sources of system instability present during liquid colloidal probe nanoscopy can easily be mitigated through proper equilibration procedures. Instabilities as discussed previously result in erroneous results and force curves that are more difficult to analyze objectively. If all sources of instability have been tended and graphs similar to that shown in Figure 4C are still present another measurement parameter may be the reason. Other measurement parameters that are important to consider during colloidal probe nanoscopy include the speed at which the cantilever is engaged and retracted from the sample and the trigger point of the force measurement. Additionally, it should be noted that the location of the colloidal probe's center may be different than a traditional AFM tip. Hence, it is advised to position the laser spot directly above the center of the probing particle to maximize measurement accuracy. 
It is important to choose a speed that is sufficient to the force one is interested in measuring and one that is suitable to use in the liquid medium. If only interested in the adhesion forces present between the particles, the speed of approach is not critical. However, for attractive and repulsive force measurements between the particles, choosing an approach and retract speed that is slow enough is important. An approach speed should be chosen to allow the interactions and not the speed to dominate the deflection of the cantilever. A fast approach will overshadow and not allow time for the attractive interactions to form, while a very slow approach in a liquid medium will produce unstable baselines similar to Figure 6C. The instability caused by a slow approach is because the 
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liquid buoyant force on the cantilever is similar to the force used in the cantilever approach.  
Another measurement parameter that should be considered prior to data acquisition is the final trigger force. Too large a trigger force can result in large deformations during the measurement and may even crush the probe or sample depending on the material properties. Alternatively, too small of a force will produce inaccurate results, as the liquid layer between the probe and sample may not be sufficiently pushed out from between the particles, thus the measured interaction is not particle-particle. Method optimization is important to properly screen and test various measurement parameters to ensure that the data obtained is representable and accurate.  
Force maps shown in Figure 7 can provide large easily obtained data sets. The resolution of the topographical map and subsequently overlayed three-dimensional representations are directly related to the number of measurements conducted. However, even though a larger number of data points will produce higher resolution images, scan times can be greatly increased. Keeping liquid measurement systems stable throughout force mapping can be challenging depending on the liquid medium and environmental controls. Liquid evaporation, which is one of the biggest concerns, can be limited by regularly ‘topping off’ of the system with additional liquid. However, it is imperative that the scan is paused and sufficient time is given for re-equilibration of the system prior to resuming the measurement. A suitable scan time should be chosen to ensure that the system can be kept stable to ensure the accuracy of the measurements.  
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The ability to conduct instantaneous force curves, dwell force curves, and large data sets of force maps conveys the versatility of colloidal probe nanoscopy in evaluating interactions present in colloidal systems in environments that mimic naturally occurring. Experimental data obtained using the method detailed here can provide key insights into colloidal stability, electrostatic interactions, and coagulation kinetics. This information can be used to screen and or improve upon present colloidal systems throughout various industries. Additionally this method can be used with biological cell lines to evaluate the effect of certain drugs or materials (prepared on a colloidal probe) on cell interactions and functions. This can provide great insight in small molecule, drug discovery and formulation design. Furthermore, with recent advances in the ability to produce submicron and even nano-colloidal probes, one can use the method presented here to study even nano-colloidal systems.   
  
115 
6. ACKNOWLEDGEMENTS 
The authors acknowledge (1) financial supports from Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine in Dankook University, and from the Priority Research Centers Program (No. 2009-0093829) funded by NRF, Republic of Korea, (2) the facilities, and the scientific and technical assistance, of the Australian Centre for Microscopy and Microanalysis at the University of Sydney. HKC is grateful to the Australian Research Council for the financial supports through a Discovery Project grant (DP0985367& DP120102778). WCh is grateful to the Australian Research Council for the financial supports through a linkage Project grant (LP120200489, LP110200316).  
7. SUPPORTING INFORMATION  
A video depicting all the detailed steps is available in the electronically published version online.   
116 
8. REFERENCES 
1. Sindel U, Zimmermann I. Measurement of Interaction Forces Between Individual Powder Particles Using an Atomic Force Microscope. Powder Technology. 2001;117(3):247-254. 2. Ducker WA, Senden TJ, Pashley RM. Direct Measurement of Colloidal Forces Using an Atomic Force Microscope. Nature. 1991;353(6341):239-241. 3. Israelachvili JN, Adams GE. Measurement of Forces Between Two Mica Surfaces in Aqueous Electrolyte Solutions in the Range 0 – 100 nm. Journal of the Chemical Society, Faraday Transactions 1: Physical Chemistry in Condensed Phases. 1978;74:975-1001. 4. Upadhyay D, Scalia S, Vogel R, Wheate N, Salama RO, Young PM, Traini D, Chrzanowski W. Magnetized Thermo Responsive Lipid Vehicles for Targeted and Controlled Lung Drug Delivery. Pharmaceutical Research. 2012;29(9):2456-2467. 5. Chrzanowski W, Kondyurin A, Lee JH, Lord MS, Bilek M, Kim H-W. Biointerface: Protein Enhanced Stem Cells Binding to Implant Surface. Journal of Materials Science: Materials in Medicine. 2012;23(9):2203-2215. 6. Chrzanowski W, Neel EAA, Armitage DA, Lee K, Walke W, Knowles JC. Nanomechanical Evaluation of Nickel–Titanium Surface Properties after Alkali and Electrochemical Treatments. Journal of The Royal Society Interface. 2008;5(26):1009-1022. 7. Tran CT, Kondyurin A, Chrzanowski W, Bilek MM, McKenzie DR. Influence of pH on Yeast Immobilization on Polystyrene Surfaces Modified by Energetic Ion Bombardment. Colloids and Surfaces B: Biointerfaces. 2013;104:145-152. 8. Page K, Wilson M, Mordan NJ, Chrzanowski W, Knowles J, Parkin IP. Study of the Adhesion of Staphylococcus Aureus to Coated Glass Substrates. Journal of Materials Science. 2011;46(19):6355-6363. 9. Binnig G, Quate C, Gerber C. Atomic Force Microscope. Physical Review Letters. 1986;56(9):930-933. 10. Butt H-J. Measuring Electrostatic, Van der Waals, and Hydration Forces in Electrolyte Solutions with an Atomic Force Microscope. Biophysical Journal. 1991;60(6):1438-1444. 11. Johnson K, Kendall K, Roberts A. Surface Energy and the Contact of Elastic Solids. Proceedings of the Royal Society of London A Mathematical and Physical Sciences. 1971;324(1558):301-313. 
117 
12. Derjaguin B, Landau L. Theory of the Stability of Strongly Charged Lyophobic Sols and of the Adhesion of Strongly Charged Particles in Solution of Electrolytes. Acta Physicochim: USSR. 1941;14:633-662. 13. Derjaguin B, Muller V, Toporov YP. Effect of Contact Deformations on the Adhesion of Particles. Journal of Colloid and Interface Science. 1975;53(2):314-326. 14. Verwey EJW. Theory of the Stability of Lyophobic Colloids. Journal of Physical Chemistry 1947;51.3:631-636. 15. Kappl M, Butt HJ. The Colloidal Probe Technique and its Application to Adhesion Force Measurements. Particle & Particle Systems Characterization. 2002;19(3):129-143. 16. Tran CT, Kondyurin A, Chrzanowski W, Bilek MM, McKenzie DR. Influence of pH on Yeast Immobilization on Polystyrene Surfaces Modified by Energetic Ion Bombardment. Colloids and Surfaces B: Biointerfaces. 2012. 17. D'Sa D, de Juan Pardo EM, de Las Rivas Astiz R, Sen S, Kumar S. High-Throughput Indentational Elasticity Measurements of Hydrogel Extracellular Matrix Substrates. Applied Physics Letters. 2009;95(6):063701-063701-063703. 18. Zauscher S, Klingenberg DJ. Friction Between Cellulose Surfaces Measured with Colloidal Probe Microscopy. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2001;178(1):213-229. 19. D'Sa D, Chan H-K, Chrzanowski W. Attachment of Micro- and Nano-particles on Tipless Cantilevers for Colloidal Probe Microscopy. Journal of Colloid and Interface Science. 2014 426:190-198.  
118 
  
119 
  
CHAPTER 4 
 
 
PREDICTING PHYSICAL STABILITY IN PRESSURIZED METERED DOSE INHALERS VIA DWELL AND INSTANTANEOUS FORCE COLLOIDAL PROBE MICROSCOPY 
 
 
This chapter has been published in European Journal of Pharmaceutics and Biopharmaceutics, 2014; 88.1: 129-135, with the title ‘Predicting Physical Stability in Pressurized Metered Dose Inhalers via Dwell and Instantaneous Force Colloidal Probe Microscopy.’ Authors: D’Sa D, Chan HK, Chrzanowski W. 
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1. ABSTRACT 
Purpose 
Colloidal probe microscopy (CPM) is a quantitative predictive tool, which can offer insight into particle behaviour in suspension pressurized metered dose inhalers (pMDIs). Although CPM instantaneous force measurements, which involve immediate retraction of the probe upon sample contact, can provide information on inter-particle attractive forces, they lack the ability to appropriately imitate all critical particle pMDI interactions (e.g. particle re-dispersion after prolonged pMDI storage).  
Experimental 
In this paper, two novel dwell force techniques – indentation and deflection dwell – were employed to mimic long-term particle interactions present in pMDIs, using particles of various internal structures and a model liquid propellant (2H, 3H Perfluoropentane) as a model system. Dwell measurements involve particle contact for an extended period of time. In deflection dwell mode, the probe is held at a specific position, while in indentation dwell mode, the probe is forced into the sample with a constant force for the entirety of the contact time. To evaluate the applicability of CPM to predict actual pMDI physical stability, inter-particle force measurements were compared with qualitative and quantitative bulk pMDI measurement techniques (visual quality and light scattering).  
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Results 
 Measured instantaneous attractive (snap-in) and adhesive (max-pull) forces decreased as a function of surface area, and adhesive forces measured by indentation dwell decreased as a function of dwell contact time for particles containing voids. This result contradicted theoretical expectations since prolonged contact times and increased contact areas (characterized by dwell measurements) normally result in increased adhesion forces.  
Conclusion  
Instantaneous force measurements provided information on the likelihood of floccule formation, which was predictive of partitioning rates, while indentation dwell force measurements were predictive of formulation re-dispersibility after prolonged storage. Dwell force measurements provide additional information on particle behaviour within a pMDI not obtainable via instantaneous measurements. 
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2. INTRODUCTION 
Most pressurized metered dose inhalers (pMDIs) are formulated as suspensions since the majority of inhalable drugs are practically insoluble in propellants (HFA 134a/HFA 227). Suspension-based pMDIs are typically robust to chemical degradation (1-3), but frequently suffer from various forms of physical instability, including flocculation, caking, partitioning (sedimentation or  creaming) and wall losses (4), all of which stem from physical particle interactions. Developments in inhaler component design and materials have reduced wall drug losses, but lack of suspension uniformity continues to be a difficult problem to control since it is governed simultaneously by propellant-particle density differences and particle interactions (5). Additionally, suspension re-dispersion is also a key factor in formulation development. Clinical studies have shown that many patients fail to properly shake pMDIs prior to administration (6, 7), resulting in inconsistent dosing which suggests that an easily dispersible formulation (requiring minimal shaking) is favorable, to ensure accurate and uniform dosing. 
Achievements in particle engineering (8), have resulted in more stable pMDI formulations. The attractive and cohesive forces present between these particles play a practical  role in the stability of these suspensions; however, the use of particle-interaction theories such as those developed by Derjaguin and Landau (9), and Verwey and Overbeek (10) (developed upon aqueous systems) are not widely accepted to predict and explain particle interactions in non-aqueous pMDI systems (11). Thus, direct measurement of inter-particle forces or flocculation and partitioning rates is necessary to understand suspension stability 
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mechanisms. Several techniques are available to evaluate pMDI suspension stability including: visual observation of partitioning (12), light scattering or reflecting particle sizing techniques for flocculation and partitioning (TurbiscanTM) (13), or dose uniformity experiments for long term physical stability evaluations (14). 
TurbiscanTM, an instrument that uses light backscattering to measure flocculation and particle concentration, is one such instrument that has been used to evaluate suspension stability (15, 16). The technique employs laser diffraction to provide quantitative information on the rate of partitioning; however, the technique does not provide any insights into the inter-particle forces that govern partitioning or re-dispersion.  
To address the limitations of bulk measurement techniques like the Turbiscan, colloidal probe microscopy (CPM) can provide quantitative insight into the nano-scale particle interactions in pMDI formulations and can be an invaluable asset during formulation development. Previous studies have used CPM to evaluate inter-particle interactions of drugs with varying surface energies or polymeric stabilizing excipients, and particle-MDI component drug interactions in model propellants (2, 4, 17, 18). However, these previous studies focused only on instantaneous force measurements as a basis for comparison, which fails to represent time-based pMDI particle interactions. The adhesion forces that govern formulation re-dispersability form over extended periods of time and cannot be accurately measured using instantaneous force measurements. To address this issue, dwell force measurements, which involve prolonged particle contact during CPM, can be used to mimic such particle interactions.  
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The primary aim of this study was to use AFM-CPM techniques – instantaneous and dwell force measurements – to emulate various pMDI particle interactions that have not been previously studied by AFM (using particles of various internal structures as a model) and reveal how the techniques can provide important information to understand particle interactions vital to the development of pMDI formulations. 
3. EXPERIMENTAL 
3.1  Spray Drying of Particles 
Spray dried particles of various surface areas were produced from an emulsified formulation containing 1,2-distearoyl-sn-glycero-r-phosphatidylcholine (DSPC), calcium chloride (CaCl2), and perfluorooctylbromide (PFOB) using previously reported methods (19, 20). In brief, DSPC, CaCl2, and PFOB were dispersed in deionized water using a high shear mixer and homogenized using a high pressure homogenizer (Emulsiflex-C55; Avestin, Canada) for several passes at a pressure above 15 kpsi before spray drying. Particles produced (denoted as A through E in this study) were of similar optical diameters (1.1 - 2.4 µm) with a wide spread of surface areas ranging from 4.2 m2/g (solid) to 76.7 m2/g (large internal void volume). 
3.2  Particle Characterization 
Optical particle size distributions were measured using a Sympatec HELOS (Clausthal-Zellerfeld, Germany) equipped with an R1 lens and Aspiros unit. Surface area was 
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measured using a 5-point nitrogen BET method (Micromertics Tristar II Surface Area  Analyzer, USA). Internal particle structures were imaged using a focused ion beam scanning electron microscope (Zeiss Auriga FIB-SEM, Carl Zeiss Microscopy, Jena, Germany); several sliced views were obtained with the following parameters: 30 kV and 250 pA at a depth of 3 µm. All SEM imaged samples were coated with 15 nm of gold.  
3.3  Atomic Force Microscopy (AFM) 
A Molecular Force Probe MFP-3D-Bio (Asylum Research, Santa Barbara CA, USA) was used for all colloidal probe measurements. After method optimization, a maximum loading force of 20 nm deflection and an approach/retract rate of 100 nm/s were set for all measurements. Prior to data acquisition, the spring constant of each probe was measured using the resonant frequency of the thermal noise spectrum and the sensitivity of each probe was calculated from the slope of the contact region in the acquired force vs. separation curves (Figure 1). All measurements were conducted in a liquid medium using 2H, 3H Perfluoropentane (HPFP) to mimic the inhaler propellant environment (21). The liquid medium was temperature equilibrated to minimize baseline deviations caused by thermal drift. 
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 F I G U R E  1  
Typical force curve obtained from an AFM/CPM measurement upon approach, contact 
and retraction of the probe. Key factors for pMDI applications are the snap-in and max-
pull forces  
A typical instantaneous AFM force vs. separation curve is shown in Figure 1. The key measured values relatable to the study of pharmaceutical pMDI formulations discussed in this paper are: snap-in and max-pull force. The snap-in is a measure of the inter-particle attractive forces during approach, while max-pull conveys the force required to overcome the adhesion between two particles upon probe retraction.  
Dwell measurements produce similar force curves with the exception of an extended probe contact region (Figure 1). The two dwell types discussed in this paper to emulate expected pMDI inter-particle interactions include: deflection and indentation dwell.  
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In deflection dwell measurements the deflection of the cantilever was kept constant for a period of time once the probe contacted the sample. To ensure that particles were in contact and not separated by a thin liquid layer, the probe was pushed to a set value determined during method optimization (max-load of 20 nm deflection). Instantaneous force measurements are equivalent to zero second deflection dwell measurements. 
In indentation dwell measurements the colloidal probe continuously indented the sample particle at a constant force throughout the dwell time. 
3.4  Colloidal Probe Microscopy (CPM) 
Three individually prepared functional colloidal probes were used for each particle type and prepared using a previously published method (22, 23). Briefly, particles were attached to Veeco tipless cantilevers (Model NP-O10 lever D with a nominal spring contact 0.06 N/m) (Veeco, Plainview, NY, USA) mounted on a custom designed 45° angle holder by using an optical microscope stage to manipulate cantilever movement to obtain a small amount of epoxy (Hardman® Double-Bubble Epoxy: Clear Impact-Resistant Water-Clear-Transparent) (Royal Adhesives & Sealants, Wilmington, CA, USA)  followed by a single particle of interest on the apex of the cantilever. All probes were checked by scanning electron microscopy (SEM) prior to and after measurements to ensure functional probes were produced and maintained throughout the measurement (Figure 2). 
For data acquisition, each probe was used to obtain instantaneous force measurements on varying regions of a single particle (n = 10). The same probe was then used to obtain 
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deflection dwell measurements (n = 10) and indentation dwell (n = 10) at various dwell times (60, 120, 180 seconds) at the same locations. Instantaneous force measurements (n = 10) were conducted again after dwell measurements to ensure that the colloidal probe was not significantly affected by the measurement process. This process was repeated for each of the three probes individually and conducted on separate days to ensure nonbiased and variable sampling (Figure 2). Each data point therefore is an accumulation of thirty individual measurements obtained using three different colloidal probes, three different substrate mounted particles, and across three different days.   
 F I G U R E  2  
SEM image of a functional colloidal probe used in this study to evaluate particle-
particle interactions and the testing scheme for each colloidal probe. 3 individually 
prepared probes were used to evaluate each particle type; and a total of 30 individual 
measurements per force technique were completed for each probe (10 each day). The 
two instantaneous force measurements not boxed were used only to check and verify 
probe functionality. Boxed measurements were used for data acquisition  
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Additionally, measurements between functional particle and glue colloidal probes on glue substrates were obtained to ensure data presented were not affected by glue-glue or particle-glue interactions. Average spring constants and the inverse optical lever sensitivity (InvOLS) values for the various particle colloidal probes used in this study are shown in Table 1.  
T A B L E  1  
Average spring constant and sensitivity (InvOLS) values ± standard deviations for all 
probes used in this study  
Probe Type Spring Constant (pN/nm) 
InvOLS 
(nm/V) 
A 61.23 ± 10.08 108.80 ±1.61 
B 64.61 ± 2.28 107.79 ± 1.42 
C 74.38 ± 12.93 108.83 ± 0.68 
D 66.72 ± 11.22 108.54 ± 0.89 
E 59.59 ± 7.68 109.33 ± 1.27 
 
3.5  TurbiscanTM Measurements 
The TurbiscanTM (Formulaction, L’Union France) was used to evaluate bulk suspension stability. TurbiscanTM samples were prepared in custom made 20 ml glass vials (Adams and Chittenden Scientific Glass Company, Berkeley, CA) by continuous valve transfer of the formulation from a pressure filled canister. Samples were prepared using a particle 
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concentration of 6 mg/ml and were thermally equilibrated (25°C) prior to and during measurements for consistency.  
Data were obtained by conducting several instantaneous measurements at a set point of 15 mm from the top of the vial for 180 seconds. This position was chosen to be situated slightly below the completely separated particle layer, thus serving as an ideal position to convey complete partitioning. There was a 10 - 15 second delay between sample agitation and measurement start, due to sample loading and instrumentation setup time. 
4. RESULTS AND DISCUSSION 
4.1  Instantaneous Force Measurements 
To ascertain the predictive ability of colloidal probe microscopy in evaluating pMDI formulation physical stability, we focused on the key attractive (snap-in) and adhesive forces (max-pull) between particles of varied measured surface areas. Particle surface area values were indicative of the internal void structure, evaluated using focused ion beam milling (Figure 3A). Measured instantaneous snap-in and max-pull forces decreased as a function of surface area, indicating that the presence of internal voids significantly reduces inter-particle forces (Figure 3 B/C).  
The snap-in forces provide quantitative data on the degree of attraction between particles, which dictates the likelihood of particle flocculation within a formulation. Flocculation is a 
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key factor preceding partitioning evidenced by the Stokes sedimentation equation (Equation 1).   
ν =  2g(ρP −  ρf)r2
9η
 E Q U A T I O N  1   The Stokes sedimentation equation calculates the speed (ν) at which a single particle suspended within a liquid medium separates by either sedimenting or creaming; where g is the gravitational constant, η the viscosity of the liquid medium, r the radius of the particle and ρP and ρf the densities of the particle and liquid medium, respectively. The formation of floccules exponentially increases the radius of the particle unit (r), which results in a significant increase in the speed of partitioning (ν). Thus, it is expected that larger snap-in forces, indicative of greater flocculation, would result in faster partitioning. The CPM snap-in forces accurately predicted rank ordering of pMDI partitioning rates as measured by the Turbiscan (Figure 3D). Conversely, the measured max-pull forces can provide information on the instantaneous re-dispersibility of the formulation as soon as floccules form, which does not hold a significant applicability to real-life pMDIs, since they are normally stored for extended periods of time before requiring re-dispersion (just before administration). Thus, the use of longer contact measurements such as dwell measurements is required.  
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 F I G U R E  3  
Measured surface area values correspond well with (A) sliced particle SEM images 
obtained using focused ion beam milling. Particle A contained the largest amount of 
voids resulting in the lowest measured snap-in and max-pull forces, while particle D 
and E were solid resulting in high snap-in and max-pull forces. Particles B and C 
contained larger and fewer voids than Particle A. Instantaneous force measurements 
show a reduction in (B) snap-in attractive force and (C) adhesive max-pull force as a 
133 
function of surface area. (D) Snap-in forces predict suspension stability, measured by 
Turbiscan. Overlaid pMDI images show the suspension quality at different stages of the 
Turbiscan measurement. As the suspension flocculates and separates the 
backscattering signal diminishes.  In the case of particle A (0.20 nN) the suspension 
remains stable throughout the measurement period, while particle E (0.44 nN) 
separates before measurement can even begin. The colours of the data points/lines in 
the graphs correspond to the coloured particle image headings  
4.2  Dwell Force Measurements 
Dwell force measurements can be used to mimic particle interactions expected for particles that remain in contact for extended periods of time, such as those present in a sediment/cream layer in a fully partitioned formulation. Two different dwell force measurement techniques, deflection and indentation dwell, were employed in an attempt to determine their ability to predict the re-dispersability of three particles of varied internal morphologies after prolonged storage. Increasing the particle contact time during CPM is expected to result in an increase in measured max-pull adhesive forces, due to the extended time allowed for additional interactions and bonds to form between the particles studied (24). However, snap-in forces should not change, since they are only affected by the initial approach, which is unchanged in dwell force measurements.   
As expected, the max-pull forces measured for deflection dwell increased as a function of dwell time for all particle types (Figure 4A). For particle E with a 4.23 m2/g surface area, the prolonged contact produced only minimal increases in max-pull forces suggesting that most of the interactions for solid particles form almost instantaneously. In deflection dwell measurements the particles are held stationary in contact, mimicking particle interactions 
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present in a formulation where stable floccules have formed but the suspension does not separate (Figure 4B). This type of interaction is not likely to be present in a pMDI, since the formation of floccules almost always results in partitioning of the suspension. To study formulation re-dispersability, it is more appropriate to mimic the effects of storage when the particles have fully separated from the liquid medium and exist as a compact layer in the pMDI, which can be accomplished using indentation dwell measurements.  
 F I G U R E  4  
(A) Max-pull adhesive forces measured using deflection dwell for three particles of 
varying internal particle morphology; particle E (4.23 m2/g); particle C (29.71 m2/g); 
particle A (76.70 m2/g). As expected, the adhesive forces increase as a function of dwell 
time for all particles.  (B) Depiction of dwell deflection force measurement: particles 
are brought into contact and held for the duration of the measurement time, 
simulating floccule formation without partitioning. Instantaneous force 
measurements are identical to a 0 second dwell deflection. Dotted line indicates initial 
point of contact between the particles 
During indentation dwell, particles are compressed into each other at a constant force (expected to occur in a creaming or sedimenting particle layer) (Figure 5A) resulting in 
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larger contact areas due to particle deformation. The increase in contact area in addition to the increased contact time would theoretically result in even larger adhesive forces and a similar trend as apparent in deflection dwell measurements. However, measured values failed to follow this trend with the exception of the solid particles (particle E) (Figure 5B). Contrary to expectation, particles with internal voids did not exhibit an increase in max-pull adhesive forces as a function of dwell time (excluding the initial jump). Additionally, adhesive forces measured by indentation dwell were lower than those obtained for deflection and this difference increased as a function of dwell time (Figure 6).  
This unexpected result is most probably a result of the “sponge-like” structure of the particles. During the indentation measurement, it is suggested that the propellant filled within the voids of the particle’s infrastructure is ‘squeezed out’. The extruding propellant opposes the force of indentation and limits contact times by breaking particle-particle contacts and preventing extended contact regions. During retraction the particles refill with propellant further limiting contact times due to the localized flow of propellant. Conversely, the continuous compression between solid particles simply results in an increase in contact area and hence increases adhesive forces as a function of dwell time. The indentation dwell measurements suggest that after prolonged storage, particles with increased internal voids should be easier to re-disperse than solid particles leading to better stability. Visual evaluation of pMDIs stored for an extended period of time (> 1 year) confirms this (Figure 5C), as evidenced by the large floccules visible in solid particle formulations even after vigorous manual agitation (Figure 5C).  These un-dispersed large floccules promote faster partitioning of the suspension. 
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 F I G U R E  5  
(A) Depiction of dwell indentation: particles are indented at a constant force for the 
duration of the measurement time, simulating compaction as in a 
creaming/sedimenting particle layer. Dotted line indicates initial point of contact 
between the particles. (B) Max-pull adhesion forces measured using indentation dwell 
for the various particles. (C) Images of formulations containing the various particles 
after 1 year storage. Particles containing more internal voids (particle A and C) 
appeared to decrease in max-pull adhesive forces as a function of dwell time, which 
translates to easier re-dispersion as evidenced by visualization of a the pMDI 
formulation (after agitation) after 1 year of storage. Max-pull forces measured for 
solid particle E increased as a function of dwell time, indicating that after they would 
be more difficult to re-disperse after prolonged storage than after the initial 
partitioning. This result is also confirmed upon visualization of pMDIs prepared with 
solid particles after 1 year of storage. Large floccules were present in solid particle 
formulations despite vigorous agitation, resulting in rapid partitioning of the 
suspension (< 30 seconds) 
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 F I G U R E  6  
Particle C max-pull adhesion forces measured by indentation and deflection dwell, 
indicative of the differing trends as a function of dwell time.  (□) deflection dwell; (◊) 
indentation dwell 
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4.3  Force Data Variability  
The recorded standard deviations existent in the force data were due to a number of variables. Individual colloidal probes used within each particle type were not identical as particles were not mono-sized and varied slightly in surface area and morphology. The surface morphology of the particle, responsible for the measurement contact area, also had an impact on the measured interactions (25). Although steps were taken to mitigate variations in surface morphology, variability still existed between powder types. The surfaces of the particles containing internal voids were smoother (Figure 7A) due to their inflated nature. Additionally, the internal voids were connected to the outer surface further reducing actual contact areas. Solid particles were still spherical, but exhibited a wrinkled surface morphology (Figure 7B), which would result in a slightly different contact area than expected for a smoother surface.  
Data variability can also be attributed to instabilities in the environment (e.g. background noises and temperature fluctuations) during the measurement. Despite these factors that contributed to data variability, clear trends were still evident for the instantaneous and dwell force measurements 
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 F I G U R E  7  
Secondary electron images of the surface morphology for (A) inflated and (B) solid 
particles. Inset images depict the expected contact areas during measurement 
dependent on particle surface morphology 
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5. FURTHER APPLICATIONS 
The ability to properly re-disperse a formulation after complete partitioning is not only important to formulation physical stability but has key implications in maintaining a uniform dose throughout the life of a pMDI product during administration. Improperly dispersed floccules, predicted by indentation dwell measurements, will result in partitioning of the suspension (Figure 5), which promotes non-uniform dosing. Previously published dose uniformity experiments conducted with particles similar to those studied here support the indentation dwell measurement trends presented in this study. Lipid spray dried with either albuterol or formoterol fumarate to produce particles with large internal void volumes exhibited fairly uniform drug dose delivery throughout the canister life (19, 26), while commercially available albuterol formulations of solid particles exhibited an increase in the delivered dose throughout the canister life (27, 28). These differences in dose uniformity are likely due to rapid flocculation and partitioning rates as a result of the difficulty to properly redisperse the solid particle formulation as shown by the present indentation dwell results.  
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6. CONCLUSION 
Colloidal probe microscopy was successfully used to measure inter-particle nano-scale forces in a similar environment anticipated in a pMDI. Instantaneous snap-in force measurements were predictive of floccule formation, which is a key factor in determining partitioning rates, while indentation dwell measurements provided key information on the re-dispersibility of formulations after prolonged storage.  
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CHAPTER 5 
 
 
NANOXCT: A NOVEL TECHNIQUE TO PROBE THE INTERNAL ARCHITECTURE OF PHARMACEUTICAL PARTICLES 
 
    This chapter has been published in Pharmaceutical Research, 2014; 1-10, with the title ‘NanoXCT: A Novel Technique to Probe the Internal Architecture of Pharmaceutical Particles.’ Authors: Wong J*, D’Sa D*, Foley M, Chan JGY, Chan HK.  
*Equal Co First Authorship 
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1. ABSTRACT 
Purpose 
To demonstrate the novel application of nano X-ray computed tomography (NanoXCT) for visualizing and quantifying the internal structures of pharmaceutical particles. 
Experimental 
An Xradia NanoXCT-100, which produces ultra high-resolution and non-destructive imaging that can be reconstructed in three-dimensions (3D), was used to characterize several pharmaceutical particles. Depending on the particle size of the sample, NanoXCT was operated in Zernike Phase Contrast (ZPC) mode using either:  1) large field of view (LFOV), which has two-dimensional (2D) spatial resolution of 172 nm; or 2) high resolution (HRES) that has a resolution of 43.7 nm. Various pharmaceutical particles with different physicochemical properties were investigated, including raw (2-hydroxypropyl)-beta-cyclodextrin (HβCD), poly(lactic-co-glycolic) acid (PLGA) microparticles, and spray-dried particles that included smooth and nanomatrix bovine serum albumin (BSA), lipid-based carriers and mannitol.  
Results  
Both raw HβCD and PLGA microparticles had a network of voids, whereas spray-dried smooth BSA and mannitol generally had a single void. However, lipid-based carriers and nanomatrix BSA particles resulted in low quality images due to high noise-to-signal ratio. 
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The quantitative capabilities of NanoXCT were also demonstrated where spray-dried mannitol was found to have an average void volume of 0.117 ± 0.247 μm3 and average void-to-material percentage of 3.5%. The single PLGA particle had values of 1993 μm3 and 59.3%, respectively. 
Conclusions 
This study reports the first series of non-destructive 3D visualizations of inhalable pharmaceutical particles. Overall, NanoXCT presents a powerful tool to dissect and observe the interior of pharmaceutical particles, including those of a respirable size. 
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2. INTRODUCTION 
Porous particles continue to be an attractive particle engineering approach to enhance aerosol performance of pharmaceutical powders (1-4). In dry powder inhalers (DPIs), porous particles can achieve emitted doses as high as 96% and respirable fractions up to 92%, whereas in pressurized metered dose inhalers (pMDIs) such particles impart better physical stability, content uniformity and aerosolization efficiency (5). Reasons for these properties could be due to reduced Van der Waals forces as well as lower aerodynamic diameters, by virtue of trapped air volume. For spherical particles, the aerodynamic diameter (𝑑𝑎) can be calculated using the equation: 
    𝑑𝑎 = 𝑑𝑝� 𝜌𝜌0 E Q U A T I O N  1  
where 𝑑𝑝 is the geometric diameter, 𝜌 is the particle density, and 𝜌0 the unit density (i.e. 1 g/cm3)  (6). 
Since this relationship has been demonstrated experimentally (7), studying the interior of particles will give important insight into their aerodynamic behavior. For example, a study by Chew et al. (8) found that a slight increase in surface corrugation significantly enhanced fine particle fraction (FPF) from 27% to 41%. Though, further increase in corrugation showed little improvement in FPF. Later, Heng et al. (9) suggested that this lack of improvement in aerosol performance of corrugated BSA (compared to smooth BSA) may be due to these corrugated particles being solid (instead of hollow). Otherwise, these 
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corrugated particles would be expected to have a smaller aerodynamic diameter and hence higher respirable fractions. 
Advanced microscopic techniques used to probe the internal structures of particles have included transmission electron microscopy (TEM), confocal laser scanning microscopy (CLSM), scanning electron microscopy (SEM), and more recently focused-ion beam-SEM (FIB-SEM). Chew & Chan (10) examined the interior of individual spray-dried mannitol by a freeze-fracture procedure. The freeze-fractured surface was replicated in carbon and then viewed under TEM. The same authors (11) later characterized the interior of spray-dried bovine serum albumin (BSA) using CLSM. Powders were fixed to a glass slide and continuous sectioning along the z-axis of the sample enabled voids to be identified. Interestingly, FIB-SEM revealed hollow interiors in particles where previous techniques had failed (10, 11). Although FIB-SEM has become a popular approach to study particle porosity (12, 13), there is a need for a non-destructive method (14) that does not introduce artifacts (9). Current methods are limited by the potential to introduce artifacts, tedious sample preparation procedures, and the destructive nature of the techniques. Furthermore, the data are only in two dimensions (2D) and remains largely qualitative. Hence, X-ray computed tomography (XCT) presents a useful complementary technique in addition to other existing methods for investigating internal structures of pharmaceuticals. 
XCT is an imaging technique where individual projections recorded from different angles are used to reconstruct the internal structure of a sample of interest. It offers extensive and non-destructive imaging that has the advantage of three-dimensions (3D). The principle of 
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XCT imaging has been extensively described elsewhere by Stock (15). In addition, the visual information has the potential to generate quantitative data. XCT has been employed to study spatial configurations, porosities and structures of soil (16), unstained soft biological tissues, and organic materials (17, 18). The pharmaceutical industry has utilized microXCT to visualize the void network of large pharmaceutical granules (> 1 mm) (19), measure density variations in pharmaceutical tablets (20), and evaluate the particle size and shape distributions for mixtures of randomly packed particles (180 - 300 μm) (21). With the recent advent of the ultra high-resolution NanoXCT, microscopic samples can now be visualized in three dimensions (3D), down to 2D spatial resolutions of 50 nm at a field of view of 16.6 µm. These settings make NanoXCT particularly suitable for characterizing individual pharmaceutical particles that may be a respirable size (22, 23).  
This study aimed to demonstrate the novel application of NanoXCT in visualizing and quantifying the internal architecture of pharmaceutical particles. Various pharmaceutical particles (small molecules vs macromolecules) with different physicochemical properties (crystalline vs amorphous) were investigated. Macromolecules included hydroxypropyl β-cyclodextrin (HβCD), a crystalline sugar, and poly (lactic-co-glycolic) acid (PLGA) microparticles, an amorphous polymer. Inhalable spray-dried formulations included smooth and nanomatrix bovine serum albumin (BSA) proteins, a lipid-based carrier, and crystalline mannitol. 
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3. MATERIAL AND METHODS 
3.1  Materials 
Raw HβCD, BSA (98% purity), and polyvinyl alcohol (PVA) (MW 31000 - 50000, 87 - 89% hydrolyzed) were purchased from Sigma-Aldrich, Castle Hill, Australia; PLGA (75:25, LACTEL Polymer) from Durect Corporation, Cupertino, United States; de-ionized water (electrical resistivity > 2 MΩ cm at 25°C) was supplied by a Modulab Type II De-ionization System (Continental Water Systems, Sydney, Australia); all solvents were analytical grade from Thermo Fisher Scientific Australia Pty. Ltd., Scoresby, Australia. 
3.2  Preparation of particles 
RAW HYDROXYPROPYL-BETA-CYCLODEXTRIN  
Raw hydroxypropyl-beta-cyclodextrin (HβCD), commercially available from Sigma-Aldrich (Castle Hill, Australia), was used as supplied. 
POLY (LACTIC-CO-GLYCOLIC) ACID  
PLGA microparticles were manufactured using a double emulsion method adapted from Kasturi et al. (24). Briefly, an aliquot of 0.5% w/v PVA in deionized water was homogenized at 7000 rpm (Unidrive X1000, CAT Scientific, Paso Robles, United States) with a 10% w/v solution of PLGA in dichloromethane. This primary emulsion was then transferred to a 5% w/v PVA aqueous solution and homogenized again at the aforementioned parameters. The resulting double emulsion (w/o/w) was left under 
152 
magnetic stirring (MR HEI - Standard Magnetic Stirrer, Heidolph Instruments, Schwabach, Germany) for four hours at room temperature to allow for solvent evaporation. The resulting PLGA microparticle suspension was subjected to centrifugation at 2000 g for 20 minutes (Minispin, Eppendorf, North Ryde, Australia) rinsed three times with deionized water, and then snap frozen in liquid nitrogen before freeze-drying (CHRIST Alpha 1 - 4, John Morris Scientific, Chatswood, Australia). Freeze drying conditions were initially maintained at -25 °C for 48 hours and then at 20 °C for 24 hours. 
SMOOTH BOVINE SERUM ALBUMIN  
Spray-dried BSA powders were prepared as described by Adi et al. (25) using a Büchi Mini Spray-Dryer B-290 (Büchi Labortechnik, Flawil, Switzerland) connected to a Büchi Dehumidifier B-296 operating at aspiration and atomization rates of 38 m3/h and 819 NL/h, respectively. An aqueous solution of BSA (60 mg/mL) was spray-dried at an inlet temperature of 55°C (outlet temperature of 38°C) and liquid feed rate of 2.4 mL/min. 
MANNITOL 
Spray-dried mannitol was kindly supplied by Pharmaxis Ltd. (Frenchs Forest, Australia). 
NANOMATRIX BOVINE SERUM ALBUMIN 
Nanomatrix BSA was produced by spray-drying a suspension containing primary nanoparticles of the protein as adapted from Kwok et al. (26). Primary nanoparticles were produced by an anti-solvent precipitation. Briefly, an aqueous solution of BSA (40 mg/mL) was rapidly poured into a volume of isopropanol (ratio of water to isopropanol was 3:7) in 
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a 600 mL beaker stirred at 6000 rpm (Silverson Model L4RT high-shear mixer, Silverson Machines, Chesham, UK). The resulting suspension was diluted with ethanol to obtain a concentration of 4 mg/mL prior to spray-drying. The spray-dryer was operated with a Büchi B-295 Inert Loop and B-296 dehumidifier, and the operation conditions were: inlet temperature at 50°C (outlet temperature 35°C), liquid feed rate at 2.4 ml/min, aspiration at 38 m3/h and atomization rate at 819 NL/h. 
LIPID-BASED CARRIERS 
Lipid-based carriers were produced from an emulsion containing DSPC, CaCl2, and PFOB (all purchased from Sigma Aldrich, Castle Hill, Australia) as previously described (27, 28). Briefly, the emulsion was homogenized using a high pressure homogenizer (Emulsiflex-C3, Avestin, Ottawa, Canada) and then spray dried with a customized commercial spray dryer (comparable to the Niro spray dryer) at settings similar to an inlet temperature of 100-110°C, outlet temperature 60 - 80°C, pump flow rate 31 mL/min, and gas flow 110 SCFM. 
3.3  Colloidal Probe Loading 
Particles were mounted onto the sharp end of a tailor pin using a similar technique described by D’Sa et al. (29). Briefly, pins were temporarily mounted on a custom 70° angle holder and manipulated using a microscope stage (Olympus CX41, Notting Hill, Australia) to approach a glass slide containing epoxy (Hardman® Double-Bubble Epoxy, Carrum Downs, Australia), which was attached to the microscope lens casing via another custom holder. Particles were sampled from the bulk and sprinkled onto a separate microscope 
154 
slide, and the same pin was then manipulated to approach a single particle or small agglomerate of interest on that slide. 
Proper loading was verified by SEM (Zeiss Evo, Carl Zeiss Microscopy, Jena, Germany). Subsequently, a gold fiducial (1.5 - 3 μm diameter) (Alfa Aesar, Wardhill, USA) was attached on or near a particle of interest (Figure 1) using a custom built manual micromanipulation apparatus fitted with 10x and 50x objectives and a video cross line generator (Boeckeler Inc, Model Via-30, Tucson AZ, USA). The gold fiducial is required to locate the particle of interest, calibrate the focus, and reconstruct the particle in 3D. 
3.4  NanoXCT Parameters and Setup 
Depending on the size of the particle of interest, NanoXCT was operated in Zernike Phase Contrast (ZPC) mode and images were acquired using either:  1) large field of view (LFOV), which has two-dimensional (2D) spatial resolution of 172 nm at a field of 65.5 μm in binning 1; or 2) high resolution (HRES) that has a respective resolution of 43.7 nm and a 
field of view of 16.6 μm in binning 1. The number of images scanned was based on binning, where a binning 1 required a minimum of 901 images. Scan times were chosen where the maximum signal detected had to be at least three times the value of the minimum detectable signal, resulting in a signal-to-noise ratio (S/N) of 3 to minimize background noise. While NanoXCT can also be operated in Absorption Contrast (AC) mode, preliminary scans for pharmaceutical materials showed that a PLGA particle was invisible in absorption compared with phase contrast imaging (Figure 1). Therefore, only ZPC mode was used in the present study.  
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 F I G U R E  1  
Comparison of (A) absorption and (B) phase contrast imaging 
 F I G U R E  2  
Schematic of the NanoXCT; Diagram not drawn to scale 
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The NanoXCT setup is depicted in Figure 2. The X-ray source is a Rigaku rotating copper anode that generates an 8 keV X-ray beam, which passes through a 5 or 10 µm Ni filter (5 µm for HRES, 10 µm for LFOV), a glass capillary condenser, and a 60 / 100 / 150 µm Ø pinhole before interacting with the rotating sample. The transmitted X-ray light is then passed through a Fresnel zone plate and a phase ring before being collected by a 1024 x 1024 Charge-Coupled Detector (CCD). 
3.5  Image Analysis 
Reconstructed axial slice stacks of each scan were processed using Avizo Fire (FEI Visualization Sciences Group, Burlington, USA) in order to qualify and quantify physical characteristics. The slices were first subjected to a non-local means filtering to reduce noise contributions to the overall dataset. A binary mask based on density thresholding was generated from this filtered dataset to separate the regions of interest from the surrounding air to further minimize noise influences. A 3D watershed algorithm was then employed to separate the agglomeration into individual particles for further analysis (30, 31). The algorithm is based on the assumption that eroding a binary image will cause features in contact to separate before they disappear (21). Subsequently, the void volume was defined as the difference between total volume of particle enclosed by a convex hull algorithm and the volume of solid material enclosed by a convex hull algorithm. The definition of solid material was based on a binarization of the data using a grey value (density) limit to determine the boundary between the solid and air. Finally, the void-to-material (%) was the ratio of void to material given as a percentage. 
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4. RESULTS 
4.1  Large Field of View (LFOV) 
The larger sized raw HβCD and PLGA microparticles were acquired under LFOV mode. Cross-sectional NanoXCT images in Figure 3A-C show that an HβCD particle contains various sized voids. Although these cross-sections are only snapshots of the particle at a specific location, when stacked together they produce a 3D representation of the whole HβCD particle (Figure 3D). This 3D representation illustrates that the particle is comprised of several interconnected voids connected to the particle surface. In contrast, PLGA particles appeared to consist of a single large internal void (completely enclosed by the particle material) surrounded by a few much smaller cavities. The large internal void is visible from the cross-sectional images, but is less apparent from the 3D representation since it is fully encompassed within the particle (Figure 4). However, this internal void becomes visible in a sliced view of the 3D reconstruction (Figure 4D).   
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 F I G U R E  3  
NanoXCT images of an HβCD particle: (A, B, C) cross-sectional images of the particle at 
various positions, and (D) reconstructed particle in 3D 
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 F I G U R E  4  
NanoXCT images of a PLGA particle: (A,B) cross-sectional images of the particle at 
various positions, (C) particle reconstructed in 3D, and (D) sliced view of the particle in 
3D 
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4.2  High Resolution (HRES) 
The smaller sized spray-dried smooth and nanomatrix BSA, mannitol, and lipid-based carriers were acquired under HRES mode. NanoXCT revealed that smooth BSA particles were mostly solid or contained a single void (Figure 5), which is in agreement with results reported by Heng et al. (9). In alignment with previous findings (32), a large proportion of mannitol particles were porous (Figure 6).  
However, NanoXCT failed to obtain clear evaluations of highly porous lipid-based carriers (Figure 7A/B) and nanomatrix BSA (Figure 7C/D) due to the high noise-to-signal ratio and poor phase contrast. Regardless of the large background noise, NanoXCT still showed that lipid-based carriers had porous internal structures (Figure 7A) similar to those found using TEM in a previous study (5). It is interesting to note that although TEM has a resolution of 50 pm, versus a spatial 2D resolution of 43.7 nm for NanoXCT in our studies, the previous study had comparable results to our findings. This highlights the challenge in producing images with clearly defined air-particle boundaries for samples that are less than 5 μm in diameter and have large void-to-material percentages.   
The reconstructed 3D particles of all samples were also processed into videos showing the completed particles rotating 360° around an axis. These can be found in the supplementary materials. 
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 F I G U R E  5   
NanoXCT images of corresponding smooth BSA particles: (A) cross-section and (B) 
particle reconstructed in 3D 
 F I G U R E  6  
NanoXCT images of corresponding mannitol particles using high resolution phase 
contrast: (A) cross-section and (B) particle reconstructed in 3D 
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 F I G U R E  7  
NanoXCT images using high resolution phase contrast: (A) cross-section and (B) 
reconstructed particle in 3D of lipid-based carriers; (C) cross-section and (D) 
reconstructed particle in 3D of nanomatrix bovine serum albumin (BSA) 
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4.3  Quantitative analysis 
Void volumes, void distributions, and void-to-material percentage of several (n = 23) individual mannitol particles (Figure 8) and a single PLGA particle (Figure 9) were obtained using watershed-based segmentation and thresholding limits to differentiate between the material and enclosed air-filled voids. Spray-dried mannitol was found to have an average void volume of 0.117 ± 0.247 μm3 and an average void-to-material percentage of 3.5%. On the other hand, the single PLGA particle had a void volume of 1993 μm3 and void-to-material percentage of 59.3%. 
 F I G U R E  8  
Rendered 3D projections of mannitol particles: (A) identified using watershed-based 
segmentation and (B) voids located within particles; color has no significance and is 
purely to aid visualization 
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 F I G U R E  9  
Rendered 3D projections of a PLGA particle: (A) particle outline, (B) voids located 
within the particle, and (C) sliced view of the entire particle; color has no significance 
and is purely to aid visualization 
5. DISCUSSION 
NanoXCT was successfully used to visualize and quantify the internal architecture of various pharmaceutical particles. This study has reported the first series of non-destructive 3D visualizations of individual micron-sized particles, including those of a respirable size. The key factor that influences the quality of images obtained by the NanoXCT is the linear attenuation coefficient (LAC). The LAC is defined as the percent reduction in intensity per unit thickness of the material, and is related to the voltage of the X-ray beam, particle 
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density and the atomic composition of the sample material. As the X-ray voltage is fixed to 8 keV in the current setup, the LAC is most likely affected by porosity and the atomic composition of the sample. The porous internal structures of the lipid-based carriers and nanomatrix BSA (Figure 7) meant these samples would have significantly lower LACs than a solid particle of the same material and size. As a result, there was minimal signal difference between the material of interest and background (air) so the particles appeared more transparent; making it difficult to distinguish between the particle and air boundaries. Alternatively, the atomic composition (a material specific property) can also play a role, in particular for the lipid-based carriers. Therefore, not all materials may be suitable for NanoXCT. While staining samples with agents such as osmium tetroxide may overcome this limitation, the staining process could introduce artifacts. 
Another important factor is the size of the particle feature to be detected. With respect to the lipid-based carrier and nanomatrix BSA particles in Figure 7, the particle features (i.e. the thin walls and primary size of the nanoparticles, respectively) approached the instrument resolution limit of 50 nm. In the case of nanomatrix BSA, even if adjacent nanoparticles are in contact, the void space would limit the signal that can be detected. 
Instrument parameters that can be optimised to improve the imaging quality are binning, scan time, and number of images. The binning value determines the image resolution, where a value of 1 would provide the highest resolution. However, using lower binning values would decrease the maximal signal and increase background noise. Thus, the binning value chosen should be based on the resolution needed to detect the smallest 
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feature. Another parameter is the scan time, which is the X-ray exposure time during a single image, and this affects image clarity. Longer scan times generally lead to greater signal and typically results in more defined material boundaries. Though, excessive scan times may not greatly improve the image quality so the minimum time that detects distinct material boundaries should be chosen. It is important to note that the definition of particle boundaries is subjective and the data arising from overlapping areas could be a source of error. Nevertheless, this issue would apply to all microscopic techniques. Lastly, the number of images taken affects the clarity and precision of the 3D rendered image. Since 3D rendering software, such as Avizio Fire, extrapolates data between images, more images would reduce extrapolation gaps and produce a more precise 3D reconstruction.  
Despite some of the limitations mentioned above, in comparison to existing advanced microscopic techniques, NanoXCT is the only non-destructive technique that offers 3D visualization. Although confocal microscopy is also capable of 3D visualization, when a material does not autofluoresce the process of labeling the feature of interest with a fluorophore could introduce artifacts. Other clear advantages of NanoXCT are that it requires little sample preparation; can be carried out under ambient conditions; the parameters do not need to be adjusted for different materials (though image quality may be improved by taking more images and using longer exposure times); it is possible to image multiple particles simultaneously within the field of view; and the method does not require the operator to be present throughout the scan, which enables efficient collection of data.   
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In addition, NanoXCT can go beyond pure visualization to extract quantitative information (33-36). The literature has shown that NanoXCT is an accurate and sensitive measure for quantitative imaging, segmentation, and identification of different phases in complex materials at the nanoscale (33). The quantitative capabilities have been demonstrated in systems such as aggregated 165 nm polystyrene particles (36), cartilage subtissues and bone architectures (35, 37), SiO2 microparticles (33), flocculated clay suspensions, and cement pastes (34); but our study is the first to report quantitative findings in pharmaceutical particles. Our results show the first examples of the use of NanoXCT to quantify void volumes (includes pores and cavities), void distributions, and void-to-material percentage – which are not possible with most advanced microscopic techniques that generate data in 2D. 
Similar to FIB-SEM, NanoXCT may also be used to correlate aerodynamic properties with porosity to explain the performance of specific formulations. While FIB-SEM has been a relatively robust method, evaluation of porosity has been limited to a percentage of particles having porous interiors. Since the NanoXCT quantifies void volumes, void distributions and void-to-material percentages, it may be a more accurate measure. However, the usefulness of NanoXCT as a tool to solve an existing problem is not only applicable to respirable particles. In pharmaceutics, the density (inversely related to porosity) of a formulation can be a measure of physical and chemical stability (38); it may determine flow properties as well as release/dissolution rates from dosage forms administered orally, parentally, rectally and topically. Hence, the insight offered by 
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NanoXCT into sample porosity could have important implications on the processing and manufacturing of pharmaceuticals. 
Overall, the 3D visual capability provides full access to the internal structures of small pharmaceutical particles. This novel technique opens up opportunities to characterize particles in greater detail and future studies will use the NanoXCT to identify different components in a mixture (i.e. physical mixtures and co-spray dried formulations) as well as compare the quantitative capabilities of NanoXCT to other advanced microscopic techniques. Another study will also attempt to use this tool to explain aerosol performance of a specific particle formulation. 
6. CONCLUSIONS 
NanoXCT presents a powerful tool to dissect and observe the interior of small pharmaceutical particles, including those of an inhalable size. It provided valuable insight into the void volumes, void distributions, and void-to-material percentage. Other advanced microscopic techniques (freeze fracture, confocal microscopy, SEM, TEM, and FIB) may complement NanoXCT to obtain a more complete picture of a particle of interest and enable aerosol scientists to better explain its aerodynamic behaviour. 
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CHAPTER 6 
 
 
ISOTHERMAL MICROCALORIMETRY OF PRESSURIZED SYSTEMS I: A RAPID METHOD TO EVALUATE PRESSURIZED METERED DOSE INHALER FORMULATIONS 
 
 
 
This chapter has been published in Pharmaceutical Research, 2014; 31 (10): 2716-2723, with the title ‘Isothermal Microcalorimetry of Pressurized Systems I: A Rapid Method to Evaluate Pressurized Metered Dose Inhaler Formulations.’ Authors: D’Sa D, Lechuga-Ballesteros D, Chan HK.  
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1. ABSTRACT 
Purpose 
The techniques available to study formulation stability in pressurized metered dose inhalers (pMDIs) are limited, due to the challenging conditions of working with high pressure propellants. Isothermal microcalorimetry is a valuable tool used to screen and aid in formulation development of solid and solution drug formulations; however there are currently no available methods to evaluate pMDIs. In this paper, we have developed a method that allows measurement of such pressurized systems.  
Experimental 
Samples were prepared by cold filling ampoules with propellant (HFA 134a) and drugs of interest. Ampoule caps were fitted with a specific O-ring, coated with paraffin and pre-conditioned prior to measurement. Samples were equilibrated at 25°C, placed in a Thermal Activity Monitor III (TAM III) system and measured isothermally at 25°C for ≥ 24 hours.  
Results 
Using well-defined procedures and ampoule preparation techniques we were able to safely contain the volatile propellant and acquire a stable measurement baseline. We were able to rapidly determine, within 6 hours, the physical stability of amorphous and crystalline drug forms of beclomethasone dipropionate and formoterol fumarate dihydrate when formulated with HFA 134a. 
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Conclusions 
Isothermal microcalorimetry in pressurized HFA propellant systems was shown to be a rapid screening tool to evaluate pMDI formulation physical stability. This method can potentially be applied to study pMDI formulation factors to expedite product development. 
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2. INTRODUCTION 
All physical and chemical processes result in the generation of a measurable heat flow, which can be studied using isothermal microcalorimetry. This technique is beneficial to formulation development because it non-destructively measures samples of any form including: solutions, suspensions, gasses, solids, and any combination thereof. Isothermal microcalorimeters, like the Thermal Activity Monitor III (TAM III), measure heat outputs on a micro/nano-watt scale, reporting the total cumulative heat (q) and heat flow (power) as a function of time. The technique is non-specific resulting in a single readout even if several reactions occur simultaneously. This allows the study of many complex reactions that are normally outside the scope of other techniques (1). However, the same non-specificity can promote erroneous analysis in the absence of appropriate controls and if sample preparation is poorly controlled.  
Isothermal microcalorimetry has been employed within the pharmaceutical industry to study a variety of formulation factors including: vapour sorption, drug/excipient stability and compatibility, polymer interactions, crystallinity, and binding energies (2-6). It has been used to aid in the development of solid drug formulations, probe solute/solvent interactions and binary mixture enthalpies, predict drug solubility of liquid formulations, and determine long term stability (7-16). 
However, despite the widespread use of microcalorimetry to study solid state and solution mediated thermal events in pharmaceutical formulations, the current techniques are not 
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transferrable to the study of pMDIs, which are becoming an increasingly popular form of drug administration as the pulmonary route is revealed to be a more efficient drug delivery pathway for many diseases (17, 18). The inability to use current analytical techniques is because of the high vapour pressure of the propellants (HFA 134a/HFA 227) – 4 to 6 bars at room temperature due to their low boiling points – which makes it challenging to safely contain the gaseous propellant and produce a hermetically sealed sample. Previous isothermal microcalorimetry pMDI studies have employed model propellants (Arcton 113 or HPFP) that differ in several properties (especially compared to HFA 134a) including solubility, dielectric constant, surface tension and water miscibility (19-22). 
Current analytical techniques used to directly evaluate pMDI formulation stability and product life involve lengthy experimental steps. For example, current procedures for evaluating pMDI product shelf life involve prolonged (> 6 months) high temperature/humidity cycling studies. These techniques depend on the Arrhenius equation to extrapolate degradation rates to room temperature based on the assumption that the degradation reactions will occur via the same mechanism at all temperatures, which however may not necessarily be true. Thus, there is a need for faster techniques to expedite direct evaluation of pMDI formulation stability and product life. 
In this paper, we provide a reliable method to study actual drug-propellant interactions using isothermal microcalorimetry, demonstrating its utility to evaluate the crystallization of suspended particles in pMDI formulations. The ability to obtain a stable baseline and accurately measure the heat produced from a formulation containing HFA 134a can 
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significantly reduce the time required to develop and optimize marketable pMDI formulations.  
3. MATERIALS AND METHODS 
3.1  Materials 
HFA 134a (Fluor Ineos United, Cheshire, UK) was the main propellant used in this study as it exerts a higher pressure than HFA 227 at the same temperature. Formoterol fumarate (FF) (Vamsi Pharmaceuticals, Maharashtra, India) a long acting beta receptor agonist and beclomethasone dipropionate (BDP) (Sigma Aldrich, Castle Hill, NSW) an inhaled corticosteroid, widely used drugs to treat chronic obstructive pulmonary disease (COPD), were chosen as model drugs to test the functionality of the TAM in screening formulations. Raw FF and BDP were crystalline. 4ml pressure ampoules were obtained from TA Instruments, fitted with specific Nitrile O-rings (Catalog #10N010, N & K Engineering Supplies PTY LTD, Marrickville, NSW) and coated with white soft paraffin (B.P.). Samples were measured using a Thermal Activity Monitor III (TA Instruments, Sollentuna, Sweden). HFA 134a was initially filled into Bespak 20mL canisters (Bespak, Norfolk, UK) using Valois valves (Model#DF30 plus, Aptar Pharma, Tokyo, Japan) to allow cold transfer of the propellant to the appropriate ampoule for measurement.  
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3.2  Preparation of Amorphous APIs by Spray Drying 
Amorphous BDP was produced via spray drying using a Büchi 290-Mini Spray Dryer (Büchi, Switzerland). BDP was spray dried from a 5% w/v ethanolic solution in closed loop using an outlet temperature of 40°C, inlet temperature of 60°C, aspiration setting of 35 m3/h, pump feed rate of ~ 3.5 mL/min, and atomizer flow of 742 NL/h. Amorphous formoterol fumarate was spray dried from a 2% w/v methanolic solution at similar settings.  
3.3  TAM Sample Preparation  
MDI canisters were cleaned with ethanol, deionized water and air dried before being crimped with Valois valves (desiccating ring removed to allow for easy removal). Crimped canisters were pressure filled with HFA 134a using a Pamasol manual pressure filler (Pamasol Willi Mäder AG, Pfäffikon Switzerland) and chilled in dry ice for 30 minutes. 5 mL syringes in their original packaging or pipette tips in a sealed specimen jar (protected from moisture), were simultaneously placed in a beaker surrounded by dry ice and chilled for 30 minutes. Ampoule caps were prepared by applying enough soft paraffin to ensure that the O-ring and the groove underneath were appropriately covered and filled (Figure 1). The ampoule bases were placed in sealed specimen jars (to protect from moisture) and placed in dry ice for the final 10 minutes of the canister and syringe/pipette 30 minute chilling step. Ampoule caps were stored at room temperature. 
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 F I G U R E  1   
TAM sample ampoule cap (A) Top view of the ampoule cap with the O-ring situated in 
the appropriate O-ring groove. (B) Sliced view of the ampoule cap showing the correct 
application of paraffin. (Inset) A closer view of the paraffin application: note that 
excess paraffin fills the gap below the O-ring in the O-ring groove. (C) TAM ampoule 
with cap and locking ring (Inset); side view of actual cap with Teflon sleeve and O-ring 
After all components had been appropriately chilled, they were transferred to a dry box (RH < 10%) and a specific amount of drug was added to the chilled ampoule. Alternatively, the drug can be weighed into the ampoule prior to chilling; however because we used amorphous drugs in this study - normally characterized by high moisture sorption rates – we added the drug after the chilling step to minimize moisture exposure. A sharp cutting plier was used to remove the valve from the chilled canister and a chilled syringe or pipette 
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tip was used to fill the ampoule (containing the drug) with the desired volume of HFA from the canister (~ 4 mL). Immediately following addition the ampoule was capped, sealed using the locking ring (Figure 1C), and transferred to a water bath set at 26°C for 5 minutes, to roughly equilibrate the sample to the measurement temperature. This equilibration step is necessary to prevent condensation/ice forming on the outside of the ampoule, which can be detrimental to both the instrument and the accuracy of the measurement. The prepared ampoules were then transferred to the TAM III and lowered into an equilibration position for 15 minutes before lowering into the measurement position. Consistency in the technique and timing used to insert the ampoules into the measurement position is vital to minimize variability in friction-generated heat during insertion. The use of proper techniques eases sample comparison by limiting the equilibration period needed to ensure that an accurate signal is obtained and artefacts are minimized. Furthermore, control ampoules should always be prepared and measured concurrently to differentiate between heat signals due to equilibration and handling, and the sample of interest. 
3.4  X-Ray Powder Diffraction  
X-Ray powder diffraction (XRPD) patterns were obtained using a Skyscan D5000 (Siemens, VIC Australia). Samples were scanned from 3° - 40° 2θ using 15 seconds per step size of 
0.01 2θ (~ 16 hour scan time). Samples from measured TAM formulations were recovered by allowing the propellant phase to slowly evaporate from the ampoule (after carefully chilling and opening ampoules) in a dry box kept below 10% RH. Samples were kept desiccated using silica gel (Chem-Supply, SA Australia) until measurement.  
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3.5  Scanning Electron Microscopy 
Samples from measured TAM formulations were recovered similarly to those obtained for XRPD analysis. All SEM samples were prepared in a dry environment (RH < 10%).  Samples were coated with 15 nm of gold and imaged with a beam current of 10 µA and voltage of 15 kV using a Zeiss Evo Quemscan (Zeiss, Carl Zeiss Microscopy, Jena, Germany). Samples were kept desiccated until measurement. 
4. RESULTS AND DISCUSSIONS 
4.1  Key Method Factors  
Sample preparation is a major component of isothermal microcalorimetric measurements. Improper handling of the sample and poorly controlled experimental procedures give rise to erroneous measurement signals that can be mistakenly interpreted as an effect of formulation design. The environmental temperature at which the samples are prepared in and the temperature at which the samples are pre-equilibrated outside of the instrument also have a measurable impact on the length of time required to achieve a stable baseline (2). There are three key controllable parameters that must be carefully considered to ensure that the signal obtained during measurement is solely attributed to formulation parameters:  1. O-Ring Conditioning  2. Paraffin Application onto Ampoule Cap 3. HFA Fill Volume  
185 
O-RING CONDITIONING  
The O-rings on the ampoule cap must be properly conditioned in order to obtain a hermetic seal and accurate measurement. To condition the O-rings, ampoules filled with HFA 134a were sealed using ampoule caps fitted with the O-rings (with paraffin applied) and stored for at least one day at room temperature. This process was performed twice consecutively to ensure that O-rings were properly conditioned. This initial conditioning allows the O-rings to swell and contract when in contact with the paraffin and propellant. Once conditioned, the O-rings can be used effectively until material failure. Failure to condition the O-rings will result in errant peaks during measurement, which can be easily misinterpreted as an effect of the formulation by an unaware user (Figure 2).    
 F I G U R E  2  
Failure to condition O-rings, results in relaxation and swelling of the O-ring during the 
measurement which produces large deviations from the baseline; (A) first conditioning 
step; (B) second conditioning step 
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PARAFFIN APPLICATION ONTO AMPOULE CAP 
The paraffin, used as a supporting sealant, must be appropriately applied as shown earlier in Figure 1 to prevent baseline drift. Improper application of paraffin will allow the propellant to leak (at uncontrollable rates) making it impossible for the liquid and vapour phases of the propellant to reach equilibrium (Figure 3). 
Filling in the gap below the O-ring is a key component in the application of the paraffin. If the O-ring is resting against the bottom surface of the O-ring groove with paraffin above, the upward force of the propellant vapour phase will push the O-ring against the more mobile paraffin; the paraffin will be pushed out of the O-ring groove allowing the O-ring to shift during measurement. Conversely, when the O-ring is resting against the top of the O-ring groove with the paraffin filled in below (Figure 1B), the upward force of the vapour phase pushes the more mobile paraffin against the O-ring (firmly situated against the immobile O-ring groove edge) filling the paraffin into any gaps present between the O-ring and ampoule wall resulting in an ideal seal.  
 
 
 
 
 
187 
 
 
  
 F I G U R E  3  
Unstable and irreproducible drifting baselines caused by the slow and variable leaking 
rate of HFA from the ampoule due to improper paraffin application 
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HFA FILL VOLUME 
The volume of HFA filled into the ampoule also affects the time required to reach a stable baseline (Figure 4). The ampoule must be filled near its capacity volume to limit head space and promote fast equilibration times. In a closed system under pressure (as in the TAM ampoule) the propellant exists as a liquid and a vapour such that the two phases will reach a steady state. The differing thermal conductivities of the two phases can result in large temperature gradients within the ampoule, greatly lengthening the equilibration times. Minimizing the volume of the vapour phase limits this temperature gradient to a smaller volume, resulting in quicker equilibration. Additionally, because we are interested in liquid propellant-drug interactions, maximizing the interaction volume is beneficial to signal output.  
 F I G U R E  4  
The amount of propellant added to the ampoule has an effect on how quickly a stable 
baseline is achieved. A variety of volumes ranging from 2.7-4.0mL were tested 
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Once all the above mentioned parameters were appropriately controlled, we were able to obtain a stable and reproducible baseline with a standard deviation of < 5 x 10-7 W/g after 5 hours and < 3 x 10-7 W/g after 10 hours (n = 6) (Figure 5). The larger standard deviation seen within the first 5 hours is due to small variations in sample preparation and environmental conditions from day to day experiments as the system stabilizes. Thus, it is always important to conduct a control sample during each experiment.  
 F I G U E  5  
The baseline achieved for a sample containing only HFA 134a with the proper sample 
preparation techniques. All samples were conducted on different days to account for 
variances in environmental temperature during preparation. (n=6) Mean and 
standard deviation shown here 
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4.2  Formulation Screening of Manufacturing Techniques and Physical Stability 
Partially amorphous beclomethasone dipropionate (BDP) spherical particles (1 - 5 µm) particles were produced by spray drying (Figure 6B). The partial amorphicity of these particles were verified with X-ray powder diffraction (XRPD) (Figure 7). Most amorphous drug forms are less stable than the crystalline forms because of the lack in long-range order, which result in a greater dissolution rate in a given solvent; the resulting concentrations form a supersaturated solution that promotes crystallization. Amorphous solids also exhibit a greater propensity for moisture, which leads to a decrease in the glass transition temperature and eventual crystallization (23).  
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 F I G U R E  6  
Beclomethasone Dipropionate SEM images (A) Micronized crystalline BDP (B) Spray 
dried amorphous BDP (C) Crystalline BDP recovered from the measured amorphous 
BDP-HFA134a formulations 
192 
 F I G U R E  7  
Beclomethasone Dipropionate XRPD patterns (A) Micronized crystalline BDP (B) Spray 
dried partially amorphous BDP (C) Crystalline BDP recovered from the measured 
amorphous BDP-HFA134a formulations 
We observed that partially amorphous BDP formulated with HFA 134a was physically unstable, characterized by a prominent exothermic heat flow peak from the sample within the first five hours (Figure 8). Analysis of large 100 µm crystalline particles recovered after the measurement confirmed that the amorphous particles underwent a dissolution-mediated crystallization in HFA 134a (Figure 6C). The heat signal is the result of the wetting of the particles by propellant, dissolution of the particles in the propellant (both endothermic) and subsequent crystallization of the partially amorphous BDP particles (exothermic). The initial endothermic wetting and dissolution of the particles are not clearly visible in the heat flow measured by TAM because they most likely occur during the measurement equilibration period.  
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 F I G U R E  8  
Normalized heat flow signal obtained for a pMDI formulation containing spray dried 
amorphous BDP in HFA 134a 
From the XRPD patterns we determined that the structure of the crystals formed in the BDP-HFA134a formulation were different from the original crystalline material (Figure 7). The difference in XRPD patterns is attributed to the incorporation of HFA-134a within the crystal structure (during the solution-mediated crystallization) to form a HFA solvate of BDP, which is the most stable form under these conditions (24).  
The amorphicity of the spray dried formoterol fumarate (FF) spherical particles (1 - 3 µm) (Figure 9B) were verified with XRPD (Figure 10B). The measured heat flow for formoterol-HFA 134a formulations was identical to HFA134a only formulations (Figure 5), indicating that the amorphous formoterol remained stable in the propellant (Figure 11). Imaging and XRPD of the recovered particles (after measurement) confirms that no visible or measurable physical changes occurred (Figure 9C and Figure 10C respectively). 
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 F I G U R E  9  
Formoterol Fumarate SEM Images (A) Micronized crystalline FF source; (B) Spray 
dried amorphous FF; (C) Recovered amorphous FF from FF-HFA 134a formulations 
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 F I G U R E  1 0  
Formoterol Fumarate XRPD patterns (A) Micronized crystalline FF source; (B) Spray 
dried amorphous FF; (C) Recovered amorphous FF from FF-HFA 134a formulations 
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 F I G U R E  1 1  
Normalized heat flow signal for a pMDI formulation containing amorphous FF in HFA 
134a 
In addition to using the amorphous components of the drugs, we evaluated the raw crystalline material for formulation stability (Figure 6A & Figure 9A). Crystalline forms of both drugs exhibited physical stability throughout the measurement (Figure 12), as evident from the resultant heat flows which are identical to that of a formulation containing only HFA 134a (Figure 5). Despite the solvate of BDP being the most stable form of the drug, the stability of the crystalline BDP is attributed to the lack of a dissolution driving force, which is necessary to incorporate HFA 134a into the solvate crystal structure. 
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 F I G U R E  1 2  
Normalized heat flow for the crystalline drug forms of (A) beclomethasone 
dipropionate and (B) formoterol fumarate in HFA 134a; both exhibit physical stability  
In an attempt to force dissolution we prepared samples containing crystalline BDP, HFA 134a and variable amounts of ethanol up to 5% w/w. Despite the use of a co-solvent, the crystalline BDP did not crystallize into the clathrate/hydrate form within the formulation during measurement (heat signals were identical to baseline signals).  
198 
5. POTENTIAL APPLICATIONS 
It is important to reiterate that the heat signals obtained from the TAM III are all encompassing and therefore heat signals obtained may be an accumulation of various processes: simultaneous wetting, dissolution, and crystallization (includes nucleation and crystal growth). Although it is possible to obtain quantitative data from the normalized heat flow curves of these reactions (including their kinetic and thermodynamic parameters) (25-27), the rapid crystallizations measured in these studied systems make it difficult to determine if we captured the complete reaction. The measured start of the reaction may be truly unidentifiable due to the speed at which it occurs and the required equilibration period (despite the optimized equilibration parameters). Therefore, samples that exhibit delayed crystallization, reaching a stable baseline before crystallizing, would be ideal quantification models.  
Even though all experiments were conducted using HFA 134a, the alternative propellant HFA 227 (which has a lower vapour pressure than HFA 134a) can also be used safely. In addition to studying crystallization, the technique presented in this paper may also be applied to evaluate excipient compatibility, moisture ingress, co-solvent concentrations, and degradation rates. The achievable stable baseline of this method combined with the high sensitivity of the TAM III provides the potential to measure drug degradation rates for 
drugs that degrade ≤ 1 % per annum (28).  
  
199 
6. CONCLUSION  
We have shown that it is possible to safely prepare ampoules containing HFA 134a for isothermal microcalorimetric measurements and obtain a reproducible baseline using proper preparation techniques. Using this method we were able to rapidly evaluate the physical stability of spray dried beclomethasone dipropionate and formoterol fumarate amorphous particles formulated in HFA 134a. The ability to measure actual pMDI formulations using isothermal microcalorimetry may shorten the required formulation development time for pMDIs. 
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CHAPTER 7 
 
 
ISOTHERMAL MICROCALORIMETRY OF PRESSURIZED SYSTEMS II: EFFECT OF EXCIPIENT AND WATER INGRESS ON FORMULATION STABILITY OF AMORPHOUS GLYCOPYRROLATE 
 
 
 
This chapter has been published in Pharmaceutical Research, 2014; 1-9, with the title ‘Isothermal Microcalorimetry of Pressurized Systems II: Effect of Excipient and Water Ingress on Formulation Stability of Amorphous Glycopyrrolate.’ Authors: D’Sa D, Lechuga-Ballesteros D, Chan HK.  
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1. ABSTRACT 
Purpose 
Use isothermal microcalorimetry to directly evaluate the effects of excipients and water content to produce a stable amorphous glycopyrrolate pressurized metered dose inhaler (pMDI) formulation.  
Experimental 
Amorphous glycopyrrolate particles with and without excipients (Distearoyl-sn-glycero-3-phosphatidylcholine (DSPC) or  β-cyclodextrin (βCD)) were spray dried and cold filled along with HFA 134a into customized thermal activity monitor (TAM) measurement ampoules. When applicable, a known amount of water was also pipetted into the ampoule. Sample ampoules were hermetically sealed, equilibrated to 25°C and measured isothermally for at least 24 hours using the TAM III (TA Instruments, Sollentuna, Sweden). 
Results 
Amorphous glycopyrrolate particles were highly unstable and crystallized rapidly when suspended in HFA 134a. Co-spray drying the glycopyrrolate with DSPC failed to mitigate this instability, but co-spray drying with βCD protected the amorphous glycopyrrolate from 
crystallization, resulting in a stable formulation at low water contents (≤ 100 ppm).  
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Conclusions 
This study shows that isothermal microcalorimetry can easily differentiate between physically stable and unstable pMDI formulations of glycopyrrolate within a few hours. Furthermore, it allows rapid screening of various formulation factors (drug form, excipients, water ingress), which can greatly reduce the time required to develop marketable products with acceptable shelf life.   
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2. INTRODUCTION 
Glycopyrrolate (GP) was recently found to demonstrate sustained bronchodilation for > 24 hours with a rapid onset of action to treat chronic obstructive pulmonary disease (COPD) (1-3). Despite this new discovery, a limited number of products are available and inhalable glycopyrrolate is yet to be approved for treatment of COPD in the United States. Currently, Novartis has the only two marketed dry powder inhalable formulations of glycopyrrolate (Seebri and Ultibro Breezhalers), while Pearl Therapeutics is in phase III clinical trials of two glycopyrrolate pressurized metered dose inhalers (pMDI) (PT001, PT003). The limited number of products pursued most likely is attributed to the highly unstable nature of amorphous glycopyrrolate produced during typical manufacturing processes and the lengthy developmental timelines to evaluate product stability.  
Manufacturing techniques such as spray drying, micronization, and spray-freeze drying are required to control drug particle size and morphology to enable efficient delivery to the lungs. However, the large mechanical stresses experienced during micronization and the fast solvent removal associated with spray drying normally produce partially or fully amorphous particles. Although amorphous drugs dissolve and are absorbed in-vivo faster than the crystalline form (4-7), they are usually more unstable and can transform into larger crystalline particles when formulated with HFA 134a/HFA 227, leading to blockages in the pMDI valve and a reduction in the respirable particle fraction. Furthermore, the amorphous glycopyrrolate glass transition temperature (Tg) drops below room temperature when exposed to even a slightly humid environment (20% - 40% RH) (8), and 
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thus can be difficult to prepare formulations that remain stable throughout the manufacturing process. 
To mitigate such instabilities in pMDI formulations, various excipients like phosphatidylcholines and cyclodextrins can be employed. DSPC is a common phosphatidylcholine used in DPIs and pMDIs such as Nektar’s Pulmospheres™ and Pearl’s Porous Particles™ (9-13). DSPC is often spray dried with CaCl2 to increase the particle Tg and thus particle stability (14); while cyclodextrins form non-covalent drug-inclusion complexes, which result in greater stability due to the protection of the complexed drug molecule (15). Although excipients are employed to improve stability, the use of an incompatible excipient can exacerbate physical instabilities and accelerate drug degradation (16). Such incompatibilities may not be noticeable instantaneously, but may develop over an extended storage time.  
Thus, long-term stability must be evaluated to ensure excipient-drug particles remain stable during storage. In storage, pMDI formulations can be largely affected by water, which enters the formulation by moisture diffusion through the valve components (17). Accumulation of water in a formulation can lead to changes in particle size distribution, particle adhesion, crystal deliquescence, crystallization, formation of hydrates, and may induce hydrolysis or act as an intermediary between solid components (18-20).  
Current techniques for evaluating pMDI long term stability and excipient compatibility require prolonged exposure (> 6 months) to elevated temperature and humidity 
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environments, and are limited by the low boiling temperature of propellants used in formulation. In part one of this series, we developed a technique using isothermal microcalorimetry to directly evaluate pMDI formulations (21). This paper aims to apply the technique as a rapid tool to evaluate whether DSPC/CaCl2 or β-Cyclodextrin can stabilize amorphous glycopyrrolate in a pMDI formulation. The technique was also used to assess the effect of water content on formulation stability, mimicking water ingress expected during normal shelf-life. 
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3. MATERIALS AND METHODS 
3.1  Spray Drying of APIs 
Spray dried particles were produced using a Büchi 290-Mini Spray Dryer (Büchi, Switzerland) using the parameters shown in Table 1. Raw crystalline glycopyrrolate was supplied by Boerhinger Ingelheim (New Castle, Pennsylvania USA). Distearoyl-sn-glycero-3-phosphatidylcholine/calcium chloride (Sigma Aldrich, Castle Hill, NSW) particles were spray dried from a dispersion in a 2:1 ratio (w/w) dispersed in 60°C deionized water using a high shear mixer (Silverson, J L Lennard Pty. LTD, Sydney NSW). β-Cyclodextrin (Sigma Aldrich, Castle Hill, NSW) particles were spray dried from solution. 
T A B L E  1   
API spray drying parameters 
Excipient GP Mass Fraction 
Solids  
(mg/mL) 
Inlet 
Temp. 
(°C) 
Outlet 
Temp. 
(°C) 
Atomizer 
Flow 
(NL/h) 
Liquid 
Feed Rate 
(mL/min) 
Aspiration 
Flow 
(m3/h) None 100% 20  88 58 - 60 360 2.5 35 DSPC-CaCl2 0% 10  85 58 - 60 360 2.5 35 DSPC-CaCl2 20% 10 85 58 - 60 360 2.5 35 
βCD 0% 10  105 60 - 61 470 – 540 3.0 35 
βCD 20% 10  105 60 - 61 470 - 540 3.0 35  
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3.2  Isothermal Microcalorimetry  
Isothermal microcalorimetry measurements were conducted using a Thermal Activity Monitor III (TAM III) (TA Instruments, Sollentuna, Sweden). This non-destructive technique allows accurate measurement of temperature changes in the sample through ultra-sensitive thermoelectric elements, which convert temperature differences to electric voltage differences. One side of the sensor contacts the sample ampoule, while an empty reference ampoule is maintained at a constant temperature by a controlled heat sink (22). Precise temperature control (± 0.0001°C), ensures that any change in heat from the sample due to physical or chemical reactions will produce a temperature gradient across the sensor resulting in a proportional measurable voltage. This change in voltage is then reported as heat flow. The technique is non-specific, therefore prior knowledge of the expected reaction(s) or post-analysis of the samples can aid interpretation of the reactions/changes occurring within the formulation.  
TAM samples were prepared using a previously published procedure (23). Briefly, pMDI canisters (20 mL Bespak Cans, Norfolk, UK) were cleaned with ethanol and DI water, fitted with metering valves (Valois DF30plus, Aptar Pharma, Tokyo, Japan), and pressure filled with HFA 134a (Fluor Ineos United, Cheshire, UK) using a hand pressure filler (Pamasol Willi Mäder AG, Pfäffikon Switzerland). Filled canisters and 5 mL transfer syringes (protected from moisture) were chilled for 30 minutes, while ampoules were chilled for 10 minutes. After the chilling step, particle samples were added to the ampoules followed by a known amount of deionized water when applicable, and finally filled with ~4 ml of HFA 134a. Ampoules were prepared in a dry environment (RH of 0 - 5%) to limit moisture 
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exposure. The filled ampoules were sealed and equilibrated for 5 minutes in a water bath at 25°C, equilibrated in the TAM III for 15 minutes and lowered into the measurement position. Samples were measured for > 24 hours at 25°C and all ampoules were weighed upon completion of the experiment to determine propellant and particle sample weights.  
The 15 minute equilibration step in the TAM III for measurement of spray dried glycopyrrolate particles was bypassed due to the rapid crystallization of glycopyrrolate when formulated in HFA 134a. Due to the abnormal measurement conditions, blank HFA 134a and raw crystalline glycopyrrolate samples were measured concurrently and exposed to the same equilibration parameters for proper baseline subtraction and comparison.  
3.3  X-Ray Powder Diffraction 
X-ray powder diffraction (XRPD) patterns were obtained using a Skyscan D5000 (Siemens, VIC Australia). Samples were scanned from 3 - 40° 2θ using 15 seconds per step size of 0.01 
2θ. Amorphous glycopyrrolate was evaluated using a Skyscan 6000 (Siemens, VIC Australia) fitted with a nitrogen stage. This setup was used to limit moisture exposure during measurement, which can greatly affect the sample. Samples of measured TAM formulations were recovered by allowing the propellant to evaporate from the ampoule (after carefully chilling and opening ampoules) in a dry box kept below 10% RH. Samples were stored desiccated using silica gel (Chem-Supply, SA Australia) until measurement. 
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3.4  Scanning Electron Microscopy 
All SEM samples were prepared in a dry environment (RH < 10%). Sample stubs were coated with 15 nm of gold for 2 minutes and imaged using a Zeiss Evo Quemscan microscope (Zeiss, Carl Zeiss Microscopy, Jena, Germany). Samples were evaluated using a beam current of 10 µA and voltage 15 kV. During the transfer of samples from preparation to coating, dry ice in a secondary container and desiccating agents were used to keep samples chilled and protected from environmental moisture. SEM samples were recovered similarly to those obtained for XRPD analysis. 
3.5  Fourier Transform Infrared Spectroscopy 
Fourier transform infrared (FTIR) spectroscopy samples were prepared using an attenuated total reflectance (ATR) crystal method on a Nicolet 6700 FTIR (ThermoFisher Scientific, MA, USA). The ATR crystal was maintained in an enclosed glove bag and purged with nitrogen to ensure samples were kept below 5% RH during the measurement. This was done to prevent crystallization of the amorphous glycopyrrolate during measurement.  
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4. RESULTS AND DISUCSSIONS 
4.1  Amorphous Glycopyrrolate 
Spray dried glycopyrrolate particles were spherical, 2 - 5 µm in diameter (Figure 1B) and amorphous (Figure 2B). The loss of sphericity in some samples may suggest that amorphous glycopyrrolate particles were unstable and started to coalesce (Fig. 1B inset). This likely occurs from exposure to ambient conditions during SEM sample preparation. Nonetheless, when adequately protected from moisture the glycopyrrolate remains amorphous, conveyed by XRPD analysis (Figure 2B). 
Amorphous glycopyrrolate experienced a large exothermic change within the first couple hours when formulated in HFA 134a (Figure 3). The exotherm was confirmed by XRPD analysis to be the effect of glycopyrrolate crystallization (Figure 2). When exposed to the propellant, the spherical amorphous glycopyrrolate particles transformed into elongated crystals (Figure 1C), while crystalline glycopyrrolate remained stable in the propellant, evident by the absence of a change in heat flow (Figure 3A). In the amorphous formulation, the minima and maxima of the heat profiles (Figure 3B) represent the dissolution (endothermic signal, indicated by a solid arrow) and crystallization (exothermic signal, indicated by dashed arrows) of the spray dried particles in HFA 134a. Multiple large peaks were present within the first 3 hours because glycopyrrolate was added in excess (related to the solubility), resulting in overlapped cycles of dissolution and crystallization.  
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 F I G U R E  1  
Glycopyrrolate SEM images of (A) micronized crystalline glycopyrrolate source, (B) 
spherical amorphous spray dried glycopyrrolate, and (C) crystalline glycopyrrolate 
recovered from measured amorphous GP-HFA 134a formulations  
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 F I G U R E  2  
Glycopyrrolate XRPD patterns of (A) micronized crystalline glycopyrrolate source, (B) 
amorphous spray dried glycopyrrolate, and (C) crystalline glycopyrrolate recovered 
from measured amorphous GP-HFA 134a formulations 
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 F I G U R E  3   
TAM III normalized heat flow signal for various formulations. (A) Crystalline 
glycopyrrolate and HFA 134a. (B) Amorphous glycopyrrolate and HFA 134a. Note: The 
heat flow for crystalline glycopyrrolate/HFA 134a is identical to the baseline HFA 134a 
only  
  
217 
4.2  Effect of Excipients 
Co-spray dried DSPC/CaCl2-GP particles were unstable in propellant as indicated by the large exothermic peak (Figure 4). Conversely, DSPC/CaCl2 particles without glycopyrrolate were stable in propellant as shown by the steady heat flow (Figure 4) and SEM images of the recovered particles (Figure 5 A/B). The instability of the co-spray dried particles was thus due to the amorphous glycopyrrolate (Figure 6B). Analysis of the DSPC/CaCl2-GP particles recovered from the measured propellant formulations showed that glycopyrrolate crystallized out of the particles and formed elongated crystals joining several particles (Figure 5D). XRPD analysis confirms the presence of crystalline glycopyrrolate post propellant exposure (Figure 6C). The lack of large peaks in the XRPD pattern for the crystallized particles is likely attributed to the possibly incomplete recrystallization and the minimal mass of crystalline glycopyrrolate relative to DSPC in the particles.  
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 F I G U R E  4  
TAM III normalized heat flow signal for HFA 134a-based formulations. Stable 
DSPC/CaCl2 particles (dashed line) and unstable co-spray dried DSPC/CaCl2-GP 
particles (solid line) 
 
 
 
 
219 
 
  
 F I G U R E  5   
SEM images of (A) spray dried DSPC/CaCl2, (B) spray dried DSPC/CaCl2 recovered from 
the measured HFA 134a formulation, (C) co-spray dried DSPC/CaCl2-GP and (D) co-
spray dried DSPC/CaCl2-GP recovered from the measured HFA 134a formulation  
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 F I G U R E  6   
XRPD patterns of (A) spray dried DSPC/CaCl2, (B) co-spray dried DSPC/CaCl2-GP, (C) co-
spray dried DSPC/CaCl2-GP recovered from the measured HFA 134a formulation, and 
(D) crystalline glycopyrrolate source material 
Unlike the DSPC/CaCl2-GP particles, measured heat flows for βCD alone and co-spray dried 
βCD-GP particles were identical to the expected baseline reading, indicating that βCD based formulations were stable in propellant (Figure 7). SEM images of the recovered particles 
confirmed that βCD-GP and βCD particles remained unchanged after exposure to HFA 134a (Figure 8). Cyclodextrins have been shown to prevent crystallization and polymeric transitions, for several solid state amorphous spray-dried drug formulations (24, 25), which may translate to particles formulated in HFA 134a. The stability afforded by 
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cyclodextrins is due to the formation of drug-inclusion complexes (26, 27). FTIR spectral analysis (1200 - 1900 cm-1 region) of a physical mixture and spray dried βCD-GP support the formation of an inclusion complex (Figure 9). The bands corresponding to the carbonyl group of glycopyrrolate in the amorphous sample and physical mixture are at 1730 cm-1, but in the spray dried material is shifted to 1736 cm-1. This shift suggests intermolecular 
hydrogen bonding between the encapsulated glycopyrrolate and β-cyclodextrin (28, 29). Previous literature also supports the formation of intermolecular hydrogen bonding between the multiple components (30) and between the secondary OH groups of β-cyclodextrin (31) in spray dried formulations. One mechanism for formation of this complex is the release of enthalpy-rich water molecules from the cyclodextrin cavity, which allows replacement with a less polar guest/drug molecule (32, 33). During spray drying of 
βCD-GP particles, water molecules are likely to be forcibly displaced from the cyclodextrin molecules, providing a significant driving force for the formation of cyclodextrin-drug complexes. Additionally several other forces may be important in the possible complex formation including van der Waal interactions, hydrophobic interactions, ring strain release, and changes in solvent-surface tensions either in solution or during spray drying. The inclusion complex formation protects the amorphous glycopyrrolate, effectively inhibiting its dissolution into the propellant and subsequent crystallization.  
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 F I G U R E  7   
Normalized heat flow of spray dried particles in HFA 134a. β-cyclodextrin only (solid 
line) and β-cyclodextrin with glycopyrrolate (dashed line) 
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 F I G U R E  8   
SEM Images of (A) spray dried βCD, (B) spray dried βCD recovered from measured HFA 
134a formulation, (C) co-spray dried βCD-GP, and (D) co-spray dried βCD-GP recovered 
from measured HFA 134a formulation 
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 F I G U R E  9   
FTIR spectra of (A) amorphous GP, (B) spray dried βCD, (C) physical mixture βCD-GP, 
(D) spray dried βCD-GP 
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4.3  Effect of Water Content 
Although formulations may initially appear stable, product shelf life and the effect of storage factors such as water ingress are major concerns for product development. pMDI formulations containing HFA 134a can absorb up to 700 ppm of water, depending on storage conditions (18, 34). Initial testing with 400 ppm of moisture added to the sample 
resulted in exothermic heat flows for both initially stable βCD and co-spray dried βCD-GP formulations (Figure 10A). The different heat profiles of the two formulations are likely 
due to varying process kinetics. The βCD-only particles rapidly absorb water molecules and coalesce (Figure 10B), which produces a nearly symmetrical exotherm (minimal tailing) (Figure 10A). However, the heat changes in the co-spray dried βCD-GP formulation occur more gradually, resulting in a positively skewed exotherm (large tailing) (Figure 10A). The skewed profile is likely due to the overlap of multiple reactions occurring within the formulation since two components (βCD and amorphous glycopyrrolate) are affected by water. The water molecules absorbed by the particles will first affect the protective structure of the particle, which may expose the encapsulated amorphous glycopyrrolate to the propellant. Once exposed to the propellant, glycopyrrolate is expected to rapidly crystallize (Figure 3A). However, XRPD analysis of the recovered co-spray dried βCD-GP particles fails to convey that glycopyrrolate crystallized out of the particles; instead measured diffraction peaks are more consistent with crystalline β-cyclodextrin (Figure 11). Furthermore, glycopyrrolate crystals [like those found in samples recovered from the unstable amorphous GP-HFA 134a (Figure 1C) and DSPC/CaCl2-GP (Figure 5D) formulations] were not present in the recovered co-spray dried βCD-GP samples (Figure 
226 
11C), suggesting that the amorphous glycopyrrolate did not crystallize in the formulation. 
This occurs because βCDs may prevent nucleation of the drug by altering bulk properties such as saturation solubilities, surface tension and cohesion (35). Additionally, they can prevent crystallization even in a super-saturated solution by selectively adsorbing into growth layers and surface imperfections, disrupting and blocking crystal growth (36). Thus, the exothermic heat flow was not an effect of amorphous glycopyrrolate 
crystallization but rather βCD crystallization, morphological changes, and various other water-particle interactions. Nonetheless, the formulation is not stable when exposed to propellant containing 400 ppm of water; and thus actions should be taken to prevent such moisture exposure. 
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 F I G U R E  1 0   
Effect of water content on formulation stability (A) Normalized heat flow of HFA 134a 
formulations with 400 ppm water; spray dried βCD [solid line] and co-spray dried βCD-
GP [dashed line]. (B) SEM image of spray dried βCD particles exposed to HFA 134a 
containing 400 ppm water. (C) SEM image of co-spray dried βCD-GP particles exposed 
to HFA 134a containing 400 ppm water 
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 F I G U R E  1 1  
XRPD patterns of (A) co-spray dried amorphous βCD-GP particles, (B) βCD-GP particles 
recovered after exposure to HFA 134a containing 400 ppm water, (C) crystalline βCD 
source material, and (D) crystalline glycopyrrolate 
To limit moisture exposure, several preventative storage measures (desiccants) and 
appropriate packaging can be used. As such, the effects of various water contents on β-cyclodextrin formulations were also studied to determine the maximum water content in which the particles remained stable. Above 100 ppm, the maximum heat flows increased as a function of water content while below 100 ppm the heat flows remained at the baseline (Figure 12A). The larger exothermic outputs correspond to greater morphological changes in the particles (Figure 12 B/C). Thus, a formulation containing 800 ppm of water experienced significantly greater particle agglomeration and morphological changes compared to 400 ppm, while a formulation containing 100 ppm remained stable.   
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 F I G U R E  1 2   
(A) Normalized heat flow for formulations with an added 800 ppm, 400 ppm, 200 ppm, 
and 100 ppm of water compared to a control. [Depicted top down in decreasing 
amounts of water]. (B) SEM image of spray dried βCD particles exposed to HFA 134a 
containing 400 ppm water. (C) SEM image of spray dried βCD particles exposed to HFA 
134a containing 800 ppm water 
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5. CONCLUSION 
We have demonstrated the effectiveness of isothermal microcalorimetry as a rapid screening tool to evaluate formulation parameters such as amorphous form, excipient composition and water content, all of which are important to assess during pMDI product development. We determined that amorphous glycopyrrolate crystallized when formulated alone or co-spray dried with DSPC/CaCl2 in HFA 134a. However, when co-spray dried with 
βCD the particles remained physically stable at low water contents (≤ 100 ppm). Furthermore, increasing the water content above 100 ppm resulted in particle agglomeration and morphological changes, which suggest that such formulations require appropriate packaging to protect from moisture ingress. The quick measurement time and high sensitivity of isothermal microcalorimetry make it a useful technique for formulation scientists to rapidly develop pMDI formulations.  
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CHAPTER 8 
 
 
GENERAL DISCUSSIONS AND CONCLUSIONS 
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      SUMMARY 
The main aim of this work was to develop analytical techniques that would support and accelerate the analysis and development of stable suspension based pressurized metered dose inhalers from a particle engineering approach. NanoXCT allowed visualization and quantification of the interior particle structure (i.e. porosity), indentation dwell CPM evaluation of the inter-particle adhesive forces expected to develop within a pMDI during storage (using a model liquid propellant), and pressurized isothermal microcalorimetry direct quantification of the heat evolved from an unstable pMDI formulation containing a hydrofluoroalkane propellant (HFA 134a/227). Together, the previous six chapters have conveyed innovative techniques that are effective for characterizing various particle properties that play important roles in the stability mechanisms of particles in propellant.   
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    FUTURE DIRECTIONS 
The majority of the work presented focused on method development in relation to pMDIs. Future studies that convey the versatility of the techniques towards not only the study of various pMDIs, but also DPIs would be beneficial. Furthermore, additional work conveying the applicability of these techniques toward understanding pMDI/DPI product performance would be valuable. 
Colloidal Probe Microscopy 
The advent of nanoparticle engineering techniques constantly pushes the limits of both instrument and sample preparation capabilities. Finer stage controls on the microscopes used to prepare colloidal probes will further improve colloidal probe preparation.  
CPM measurements obtained in a model propellant are more representative than those obtained in air, but remain only an indication of, rather than a direct measurement of the inter-particle forces present in a pMDI formulation. The development of an AFM capable of evaluating colloidal probe interactions in liquid at high pressures would provide more valuable information to understand the particle interactions present directly in HFA propellants. Recently, Lea et al.1 imaged the topography of solid surfaces in contact with supercritical CO2 at pressures well above those experienced in a pMDI formulation. Thus, 
                                                        1 Lea AS, Higgins SR, Knauss KG, Rosso KM. A High-Pressure Atomic Force Microscope for Imaging in Supercritical Carbon Dioxide. Review of Scientific Instruments. 2011;82(4):043709. 
 
238 
using this type of setup it would be advantageous to evaluate particle adhesive and attractive forces directly in HFA 134a/227. Such measurements would be directly transferrable to the actual pMDI product.  
Nano X-Ray Computer Tomography 
Particle morphology, both internal and external, will affect density, aerodynamic diameter, and particle contact areas. These properties not only have an effect on physical stability in the formulation, but also affect the respirable fine particle fraction in both pMDIs and DPIs. Future studies can employ NanoXCT as a tool to measure and determine aerodynamic diameter and particle density. Accuracy of this measurement can be verified by preparing particles of various internal morphologies (i.e. changing porosities or internal void to material ratios) and comparing NanoXCT calculated values to those obtained via normal cascade impactor techniques. Furthermore, correlating calculated values to lung deposition profiles would link NanoXCT particle analysis directly to patient efficacy.   
Pressurized Isothermal Microcalorimetry 
The physical and chemical stability of a formulation is critical for initial formulation development and measuring and optimizing product shelf life. A rapid assay to evaluate excipient compatibility, the effect of moisture ingress, and the effect of the particle manufacturing process is vital during formulation development. Pressurized isothermal microcalorimetry was shown to be an effective tool for rapid analysis of pMDI formulations. Additionally, the technique has the capability to measure long term drug 
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degradation rates. Complimentary analysis of drug degradation rates using pressurized isothermal microcalorimetry and traditional storage and cycling studies could be completed. Furthermore, because the limiting factor in isothermal microcalorimetry of pressurized systems is the pressure rating of the sample ampoule, additional customization of the ampoule could support analysis at elevated temperatures; thus allowing for faster analysis of drug degradation rates and formulation stability at stressed conditions.  
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     FINAL REMARKS 
The ability to deliver a variety of drugs for the effective treatment of several diseases (not only limited to asthma and COPD) using the pulmonary route is a strong driving force for the rapid development of efficient and stable pMDIs. Thus, there is a strong desire for analytical techniques that support the rapid analysis of particle and formulation properties that impact final formulation stability and efficacy. Advances in nanoXCT, colloidal probe microscopy, and pressurized isothermal microcalorimetry, discussed in detail within this thesis, provide more detailed and rapid analysis of important particle properties for particles suspended in HFAs.  
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INTRODUCTION
Isothermal microcalorimetry is a proven technique to evaluate vapor sorption, drug/excipient 
compatibility and predict long term stability in solid and liquid pharmaceutical formulations [1-5]. 
However, it has not been used to evaluate pressurized metered dose inhaler (pMDI) formulations 
directly. This is due to the inability to safely contain commonly used propellants such as HFA 
134a and HFA 227, which exist as liquids only below -26°C and exert a pressure of four to six bars 
at 20°C, making them difficult to work with at room temperatures. The development of a new 
method has allowed the study of actual pMDI formulations using isothermal microcalorimetry 
[6]. In this study, we evaluate the effect of various manufacturing processes on the degradation of 
aspirin in hydroxy-β-cyclodextrin/aspirin particles and evaluate the effect of moisture on particle 
stability using co-spray dried formoterol fumarate/lipid particles in HFA 227. 
METHODS
MDI canisters, pressure filled with HFA 227 (Fluor Ineos United, Cheshire, UK) using a Pamasol 
manual pressure filler (Pamasol Willi Mäder AG, Pfäffikon Switzerland), and 5 mL syringes 
(protected from moisture in a beaker) were chilled in dry ice for 30 minutes. Thermal activity 
monitor (TAM) sample ampoule caps (TA Instruments, Sollentuna, Sweden) were fitted with 
nitrile O-rings (Catalog #10N010, N & K Engineering Supplies PTY LTD, Marrickville, NSW), 
coated with soft white paraffin (B.P.) (Figure 1) and stored at room temperature. TAM ampoule 
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bodies were placed in sealed plastic containers (to protect from moisture) and chilled in dry ice for 
10 minutes. After complete chilling, ampoule bodies were removed and filled with specific amounts 
of the model formulated drugs. To study the effect of water content, a known amount of deionized 
water was pipetted onto the inner wall of the chilled ampoule body, freezing immediately upon 
contact with the wall and remaining separate from the drug-containing particles during the filling 
process. Chilled MDI canisters were opened using a sharp cutting tool and syringes were used to 
add ~4 mL of propellant to the ampoule body prior to capping and securing the cap of the ampoule 
using the locking ring (Figure 1).
Figure 1.   Ampoule used to study pressurized systems. Inset: cross section of ampoule cap showing O-ring 
placement and paraffin application. 
Ampoules were equilibrated in a 36°C water bath for five minutes, then equilibrated for 
15 additional minutes in the isothermal microcalorimeter (Thermal Activity Monitor III, TA 
Instruments) prior to being lowered to the measurement position. Samples were given a minimum 
of one hour to stabilize once lowered to the measurement position to ensure measured heat signals 
were an effect of formulation parameters and not an artefact of sample insertion. All samples were 
evaluated isothermally at 35°C for an extended period of time (≥ 14 days). This temperature was 
chosen to promote degradation while maintaining a safe pressure (~7 bars) within the rating limits 
of the sample ampoules (maximum of 9-10 bars). 
Hydroxy-β-cyclodextrin (HβCD) and aspirin co-manufactured particles were prepared 
from aqueous 1:1 molar ratio solutions using three different manufacturing techniques, freeze drying, 
spray-freeze drying, and spray drying. Freeze dried particles were obtained from solutions frozen 
using liquid nitrogen and freeze spray-dried particles from solution droplets sprayed into a beaker 
of liquid nitrogen using a sonic atomizer nozzle (Sonozap Atomizer, Model# 130K50ST) with a 
flow rate of 0.5 ml/min. Freeze drying was performed in a lyophilizer (Christ Alpha 1-4) at -16°C 
for two days, while spray drying was done using an outlet of 60°C-65°C, aspiration flow of 35 m3/h, 
and liquid flow of 2.5 ml/min (Büchi 290-Mini Spray Dryer).
Co-spray dried solid amorphous formoterol fumarate/lipid particles were produced by 
spray drying an aqueous dispersion (8mg/ml total solids loading, in which formoterol fumarate 
accounted for 40% by weight) using an outlet temperature of 85°C, aspiration flow of 35 m3/h, and 
liquid flow of 2.5 ml/min. 
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RESULTS AND DISCUSSION
Cumulative heat versus time profiles measured for the various formulations containing HβCD and 
aspirin are shown in Figure 2. The differences observed in the cumulative heat over the measured time 
represent aspirin degradation profiles, which are dependent on the manufacturing process. This was 
confirmed using high performance liquid chromatography (HPLC) and results are shown in Table 1. 
 The initial endothermic event observed in Figure 2C for the spray dried formulation, 
followed by an exothermic change may be the result of multiple interactions simultaneously 
occurring. Isothermal microcalorimetry is a nonspecific technique, thus the heat measured is the 
resultant of all processes occurring within the system studied. Figure 2D represents a control HβCD 
formulation.
Figure 2.  Normalized cumulative heat for various co-manufactured HβCD-Aspirin particles in HFA 227: 
A) freeze dried; B) freeze spray dried; C) spray dried; and a control; D) HβCD only freeze dried 
particles in HFA 227.  
Table 1. 
Total % aspirin degraded from samples recovered after isothermal microcalorimetric  
analysis (14 days) measured by HPLC (n=3).
The effect of water content on the stability of the amorphous formoterol fumarate in 
spray dried formoterol fumarate/lipid particles was studied using samples prepared by spiking 
formulations with known quantities of water to mimic extreme levels of water ingress (400-900 ppm 
of water) [7, 8]. The atypical water amounts added leads to formulation instability as depicted 
by the endothermic and exothermic heat flows in Figure 3. Both curves B and C in Figure 3 
initially have an endothermic event, which could be due to the water dissolving into the propellant 
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phase or formulation components dissolving into the water propellant blend. Following the 
endothermic dissolution peak, the formulation prepared using 900 ppm of water (Figure 3, curve C) 
is immediately destabilized as evidenced by the large exothermic peak, which is characteristic of 
phase changes such as crystallization. The formulation containing 450 ppm of water (Figure 3, 
curve B) appears to have a larger endothermic peak initially before showing signs of exothermic 
instability indicated by a steady increase in heat flow. In contrast, the formulation devoid of added 
water (Figure 3, curve A) is stable. The zero heat flow in curve A also indicates that the propellant 
is properly contained during the measurement.
Figure 3.  Normalized heat flow of formulations containing co-spray dried formoterol-lipid particles and 
various water contents : A) 0 ppm; B) 450 ppm; C) 900 ppm.
CONCLUSIONS
The use of isothermal calorimetry to determine degradation profiles for formulations obtained by 
various manufacturing processes or in the presence of different moisture content levels in pMDIs 
has been demonstrated. This technique can potentially be used to expedite pMDI formulation 
development and to predict product shelf-life. 
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ABSTRACT SUMMARY 
This study presents NanoXCT as a new 
technique for observing internal structures of an 
inhalable particle. The information gained may 
complement other advanced microscopic 
techniques to assess properties of inhalation 
aerosol particles. 
 
INTRODUCTION 
Porous particles have been an attractive 
particle engineering approach to develop 
inhalable therapeutics [1]. Current methods to 
study internal structures of porous particles are 
limited by the potential introduction of artefacts, 
tedious sample preparation procedures, and tend 
to be destructive in nature. Spray-dried mannitol 
was freeze-fractured to examine the interior of 
individual particles [2]. The fractured surface 
was replicated in platinum/carbon and then 
viewed under transmission electron microscopy 
(TEM). But a later study using focused ion 
beam-scanning electron microscopy (FIB-SEM) 
revealed a hollow interior in these particles [3]. 
Chew & Chan [4] have also characterized the 
interior of spray dried bovine serum albumin 
(BSA) using confocal laser scanning 
microscopy (CLSM).  Powders were fixed to a 
glass slide and voids were detected by 
continuous sectioning along the z-axis of the 
sample.  Interestingly, CLSM failed to identify 
voids in spherical BSA. Again, FIB-SEM 
proved that there was indeed a difference in 
porosity between spherical and corrugated BSA 
[3]. Although FIB-SEM has become a popular 
approach to analyze the interior of inhalation 
aerosol particles [5, 6], there is a need for a non-
destructive method that does not introduce 
artefacts. 
While X-ray microtomography (MicroXCT) 
has been used to investigate pharmaceutical 
materials, there are only a handful of examples. 
A study by Miller & Dey used MicroXCT to 
make non-destructive density measurements of 
compacted samples of lactose powder [7]. 
Alternatively, Stuart & Clarke [8] used 
MicroXCT to examine inhaler hardware during 
the development phase to assess interactions and 
detect causes for device failure. Now, X-ray 
nanotomography (NanoXCT) has made it 
possible for ultra high-resolution 3D 
visualization of microscopic samples, down to 
2D spatial resolutions of 50 nm at a field of 
view of 16 µm or down to 150 nm at a field of 
view of 65 µm, which is particularly suitable for 
measuring individual respirable particles. This 
study aimed to demonstrate the application of 
NanoXCT as a tool for probing the interior of 
pharmaceutical aerosols for inhalation.  
 
EXPERIMENTAL METHODS 
Porous poly(lactic-co-glycolic) acid (PLGA) 
particles were prepared by double 
emulsification followed with freeze-drying. 
Individual particles were mounted on metal pins 
using a novel micromanipulation technique 
described by D’Sa et al. [9], and proper loading 
was confirmed using a Zeiss Evo scanning 
electron microscope (Carl Ziess Microscopy, 
Jena, Germany). Probes were secured onto the 
stage and imaged, under ambient conditions, in 
Zernike phase contrast mode at 8 kV using the 
NanoXCT-100 (Xradia, Pleasanton, USA). 
Subsequently, axial 2D slices were 
reconstructed from the projection images using 
computer software (TXMReconstructor, Xradia, 
Pleasanton, USA). From this image stack 3D 
images including the interior structure of the 
sample were rendered. These 3D images can be 
arbitrarily cross-sectioned and manipulated as 
desired.  
 
RESULTS AND DISCUSSION 
 Since NanoXCT required little sample 
preparation and could be carried out under 
ambient conditions, this minimized the potential 
to introduce artefacts. The results revealed that 
spray-dried PLGA had an interconnected 
network of pores (Figure 1). Non-destructive 
visualization of such a distribution of pores has 
not been reported in the literature for inhalable 
pharmaceutical particles. 
 
 
 
Figure 1. a) SEM image of pin mounted with 
PLGA, b) NanoXCT phase contrast image of 
the PLGA particle, and c) a cross section of the 
3D reconstructed PLGA particle. 
 
CONCLUSION 
NanoXCT was successfully applied to 
dissect and observe the interior of an inhalable 
PLGA particle. The information gained may 
complement other techniques (SEM, TEM, and 
FIB) enabling inhalation aerosol scientists to 
obtain a more complete picture of a particle to 
better explain its aerodynamic behavior. 
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Abstract 
Inhaled pharmaceuticals continue to be an important dosage form for addressing current and 
future therapeutic needs. A wide variety of particle engineering techniques have emerged 
over the past decade, which has led to the development of novel formulations for pulmonary 
drug delivery [1]. In particular, porous particles have been an attractive approach to enhance 
aerosol performance of pharmaceutical powders [2]. 
While there has been substantial work performed on the external features of the particles, 
there are limited or conflicting reports regarding their internal structure. Carbon replicas of 
freeze-fractured mannitol [3] and spray-dried bovine serum albumin (BSA) [4] have been 
examined under TEM and confocal laser scanning, respectively. The resulting data 
suggested the particles had solid interiors. Interestingly, when the same group utilised FIB-
SEM on the mannitol and BSA microparticles an internal porous network was revealed [5]. 
Preliminary studies using MicroXCT on other pharmaceuticals powders indicated that XCT 
could be used to determine whether the internal pores observed via FIB-SEM studies were 
the result of induced artefacts, or if instead the pores had somehow eluded detection in the 
prior works.  
NanoXCT is advantageous for the characterization of pharmaceutical particles, including 
those of an inhalable size (less than 5 µm). This is because the obtainable spatial resolution 
of 50-150 nm allows for high-resolution internal structures to be identified.  
Internal pores were observed within BSA and mannitol, corroborating the results obtained 
from FIB-SEM. The benefit of using the NanoXCT for this measurement is the minimisation 
of artefact introduction and non-destructive 3-dimensional data collection. As a result, 
NanoXCT is a powerful complementary technique to aid in the development of 
pharmaceutical powders for inhalation. 
   
Figure 1: NanoXCT of a mannitol sample (left) showing a cavity (centre) and the cavity filled (right)  
Bounding cube represents 5µm in each dimension 
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